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General Overview 
 
The Department of Health Policy of Jefferson Medical College is committed to 
conducting research and education programs, which contribute to the quality, 
safety and cost-effectiveness of healthcare.  The Department’s activities are 
meant to inform decisions made by government policy makers, providers, payers 
and other system stakeholders about how best to deliver and finance care in order 
to improve the health of the public. 
 
As reflected in this Departmental mission statement, the Department of Health Policy’s work is 
central to the strategic plan of Thomas Jefferson University.  Specifically, “Health Policy and 
Population Health” is one of the five key strategic priorities as approved by the TJU Board of 
Trustees.  The Department looks forward to the challenge of participating in this strategic 
priority and has organized its activities in this past academic year to meet that challenge. 
 
Currently, the Department is proud to be celebrating its fourth anniversary, building on the 
previous 14-year history of the Office of Health Policy and Clinical Outcomes.  Our research and 
education programs span a broad spectrum of policy issues including quality and safety 
improvement in health care, development and implementation of evidence-based care protocols, 
evaluation of healthcare delivery and financing programs, economic evaluation of healthcare 
interventions (drugs, devices and programs), and development and implementation of best 
practices for improving the health of the public.  A table of organization for the Department is 
included as an Appendix to this report. 
 
The mission of the Department is implemented through three main strategies—education, 
research and policy consulting services—which will be described in more detail later in this 
report.  In this introductory section, we will further delineate the connections between the 
University’s top strategic priorities, the Departmental mission, and aspects of our work. 
 
Healthcare Quality and Safety 
 
One of the core components of the Department’s mission is improving the quality and safety of 
medical care.  The Department has made great progress on this front during the past academic 
year.  On the national level, the Department serves as the editorial home for the American 
Journal of Medical Quality, one of the key peer-reviewed journals in our field.  In late 2006, 
AJMQ published a special supplement entitled “Hospital-Acquired Infections:  Raising the 
Anchoring Heuristic.”  This supplement was the focus of a special briefing at the National Press 
Club in Washington, DC on Monday, November 20, 2006.  This press briefing attracted 
tremendous national attention as the contributors to the supplement described their path-breaking 
findings: that hospital-acquired infections are largely preventable, very expensive, and not 
necessarily linked to the severity of illness of the patients upon admission.  In short, the AJMQ 
Supplement and the resulting national press attention clearly linked failed processes to an 
increase in hospital-acquired infection.   
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Through the publication of this special supplement and the national press conference, the 
Department’s work was featured in more than a dozen national publications, including USA 
Today, The Wall Street Journal, Pittsburgh Post-Gazette, Philadelphia Inquirer, AARP Bulletin, 
and Modern Healthcare.  Aspects of this important national work grew out of the Chair’s 10-
year tenure as the Chairperson of the Technical Advisory Group of the Pennsylvania Healthcare 
Cost Containment Council (PHC4), original sponsors of the first statewide, tax supported HAI 
Report.  It is important to therefore link ongoing consulting work by the Chair, with research 
dissemination through our journal, and changes in the public’s perception about important 
quality related issues such as hospital-acquired infection.  The Department contributes mightily 
to the national debate about improving the quality and safety of healthcare through these 
activities. 
 
On a state policy level, we collaborated with a team from Baylor Health Care System in Dallas, 
Texas, to conduct a demonstration project to implement rapid-cycle quality improvement 
strategies at two rural community hospitals in Pennsylvania.  The project, referred to as 
“Accelerating Best Care in Pennsylvania”, was funded by the Commonwealth of Pennsylvania 
through a grant to a non-profit organization called Improve Pennsylvania Community Care.  
Members of the Jefferson-Baylor team conducted a site survey and interview with each of the 
hospitals to identify areas for improvement.  In January and February 2007, the team provided 
specialized two-day education and training sessions.  These were followed by telephonic and on-
site coaching and support, to assist the hospital teams in developing their projects, refine their 
objectives and measures, and troubleshoot the implementation of their self-identified quality 
improvement initiatives.  The results were shared in a special session in June 2007 at the State 
Capitol Building in Harrisburg, Pennsylvania, and are now being prepared for publication.   
 
We also are working diligently to support continuous quality improvement on the Jefferson 
campus.  As described further below, in the “Patient Care” section, through the Department’s 
leadership and staffing for the Jefferson University Physicians (JUP) Clinical Care 
Subcommittee, we are helping each JUP Department to implement performance measurement 
and improvement initiatives, and to implement activities to support pay-for-performance 
initiatives emanating from Independence Blue Cross, Medicare (CMS), and other payers.  We 
also are among the first academic group practices to implement the Physician Practice Patient 
Safety Assessment (PPPSA), a national safety measurement tool developed by the Medical 
Group Management Association, the Institute for Safe Medication Practices, and the Health 
Research Education Trust.  The tool is helping JUP practices to identify safety deficiencies in the 
ambulatory setting and to design appropriate improvements.   
 
Other quality and safety initiatives include developing a national migraine quality measurement 
set, and collaborating with Quality Insights, the Pennsylvania Quality Improvement Organization 
(QIO) on the development of provider-specialty-specific quality measures which could be 
incorporated into public reporting and pay-for-performance initiatives.  All of these activities 
have put Jefferson at the forefront in the quality measurement and improvement movement.  Our 
collaborative work with the University HealthSystem Consortium has demonstrated that 
Jefferson is now among the nation’s top academic health centers in terms of its programs to 
improve ambulatory quality. 
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Health Information Technology 
 
Another good example of the Department’s role in the national debate to improve the quality and 
safety of healthcare through consumer engagement is our ongoing consultative work with a 
number of health information technology organizations in the private sector.  For example, this 
past year, the Department continued its affiliation with the global personal health record (PHR) 
company InterComponentWare (ICW), headquartered just outside Frankfurt, Germany.  For 
more than two years, the Department has managed a national advisory board of experts drawn 
from across the health information technology spectrum.  Work of the ICW-DHP Advisory 
Board was also featured in a special supplement to AJMQ.  In addition, members of the National 
Advisory Board then deployed back to their principal organizations (i.e., the Medical Group 
Management Association (MGMA), the Center for Governance of the American Hospital 
Association (AHA), Partnerships for Healthcare in Boston and others) to further disseminate the 
joint work of the Advisory Board and the Department.  Aspects of the Advisory Board’s 
activities were also featured in an important story in Modern Healthcare.   
 
Other contributions to the information technology debate at the national level include our work 
with GetWellNetwork®, a privately held organization based just outside Washington, DC that is 
committed to bringing the Internet to every patient’s hospital bed.  Original research conducted 
by the Department is seeking to demonstrate the power of bedside Internet access on quality of 
medical care for inpatients, their level of satisfaction, and related outcome measures.  We are 
conducting similar activities with a Chicago-based firm and their key product, Care Pages. 
 
On the Jefferson campus, our JUP performance measurement team is working closely with the 
Allscripts Touchworks© electronic health record implementation team, to ensure that the EHR 
system is aligned with national and local quality data reporting initiatives, and that clinical 
Department record templates include appropriate quality indicators.  
Coordination of Care 
Other issues critical to improving care at the national level include improving care coordination, 
especially for individuals with chronic diseases.  Once again, the Department draws on its 
various resources to consult with the private sector, publish research in scholarly peer-reviewed 
journals, and hold national conferences regarding these activities.  For example, the Chairman 
continued to serve on the board of two publicly-held chronic care management (sometimes 
called disease management) companies: Informedix (OTCBB:ISMX), based in Rockville, 
Maryland, and the I-Trax Corporation in Philadelphia, Pennsylvania (AMEX: DMX).  In 
addition to the Chair’s activities, the Department serves as the editorial home for Disease 
Management, the only peer-reviewed scholarly journal in the field of chronic care management 
and improvement.  Disease Management is also the official journal of the Disease Management 
Association of America (DMAA), headquartered in Washington, DC.  For the fourth consecutive 
year, the Department hosted the annual Disease Management Colloquium in Philadelphia.  This 
meeting has outgrown its initial home on the Jefferson campus, and is now held at a major 
downtown hotel, where it attracts more than 350 attendees and expert faculty from across the 
nation.  By connecting our research, education, and policy consulting agendas, we are able to 
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influence the national conversation about the care of persons with a chronic illness.  More about 
these activities follows later in this report. 
Improving Access 
Certainly, improving access to medical care is another important national population and health 
policy issue.  This past year, the Department broadened its research agenda and continued in its 
advisory role with Take Care Health Systems, a leading company in the convenient care arena  
headquartered in Conshohocken, Pennsylvania. Take Care, recently purchased by the national 
Walgreen’s drug store chain, is part of a new national trade association called the Convenient 
Care Association (CCA).  Convenient care, which promotes easy access to non-emergent 
primary care delivered by highly trained nurse practitioners in a kiosk-like format inside chain 
drug stores, is a “disruptive technology” that has changed the access-to-care landscape in the 
United States. 
One of the Department’s research divisions organized a group of Jefferson Medical College 
faculty to review in detail the practice guidelines utilized by Take Care’s nurse practitioners.  
This enabled Take Care to effectively promote cutting-edge, evidence-based practice, certified 
by Jefferson Medical School faculty members.  The Department is working with Take Care to 
create a research agenda, helping them to further refine the outcome measures of the care they 
are currently delivering across the country. The Chair also serves as the Chair of the national 
Take Care Medical Advisory Board, which creates medical policy, reviews practice guidelines 
utilized by the nurse practitioners, and helps inform the leadership of Take Care regarding 
strategic issues for the future.   
Within Philadelphia, the Department continues to work closely with community-based 
organizations to address issues of access to appropriate, timely, high-quality care.  Our ongoing 
work with the Health Federation of Philadelphia has been examining the impact on 
pharmaceutical access and compliance of a pharmacy access program in community health 
centers.  We also have begun to explore research collaborations with the Maternity Care 
Coalition, Philadelphia Coordinated Health Care, and other community-based organizations to 
evaluate strategies for improving care access. 
Drug Safety and Cost-effectiveness 
Improving the safety and cost-effective use of pharmaceuticals is another critically important 
national quality and safety issue.  The Department participates in these activities in a number of 
different ways.  First, the Chair is very active with the National Quality Forum (NQF) in 
Washington, DC, and this past year led one of the critical technical advisory panels (or TAPs).  
This particular TAP dealt with the appropriate use of pharmaceuticals in the ambulatory setting.  
The work of the TAP filters up through the policy-making apparatus of the NQF.  Payer 
organizations, including the Center for Medicare and Medicaid Services (CMS), adopt many of 
the recommendations from the NQF.   
Faculty members within the Department made national news this year regarding their research in 
the cost-effective and appropriate usage of Erythropoietin-Alpha (EPO-a).  It was clear to senior 
Departmental faculty that there might be inappropriate usage of this important, expensive 
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product.  Aspects of published research by our faculty received wide attention in the press.  
Furthermore, one of our senior faculty members was invited to testify in front of Congress on 
Capitol Hill regarding her research findings about the inappropriate use of EPO-a in dialysis 
centers.   
Finally, the Chair writes a monthly editorial in the national journal Pharmacy and Therapeutics.  
P & T reaches an audience of nearly 60,000 across the United States on a monthly basis.  This 
publication provides a forum for the Department to influence the policy debate regarding the 
appropriate use of medication and the cost-effective use of healthcare resources.  Editorials this 
past year have focused on a number of timely topics, including medication safety, the role of the 
TAP, and inappropriate use of EPO-a.   
Educational Symposia and Publications 
The intersection of nationally important health policy issues, the research agenda of the 
Department, and scholarly publications emanating from the Department is an important story.  
Other aspects of the Department’s story this past year include the education and training 
priorities as articulated in our mission statement.  The Department continues to be the central 
JMC clearinghouse for educational programming related to health reform, the safety of medical 
care, and leadership training for the future.   For example, in November 2006 the Department 
created and hosted “Medicine 2020: Focusing the Vision of Medical Education,” a Dean’s 
conference which attracted several hundred stakeholders to hear from leading medical educators 
about the future of medical education.  In January 2007, the Department hosted the third annual 
Interclerkship Day, a full-day program devoted to patient safety exclusively designed for the 
third year JMC Class. As the 2006-2007 academic year concluded, the Department was 
preparing for the 13th Annual Summer Seminar, “Rx for Pennsylvania: Healing the Healthcare 
System,” attended by over 225 persons, highlighting the growing political agenda for health care 
reform in the Commonwealth.  These important programs are recorded and made available via 
podcast through the Department’s web site for those who were unable to attend in person.  
Through the combination of live and asynchronous availability, these various educational 
offerings disseminated the work of our faculty, reaching thousands of persons on and off our 
campus.   
Key publications that emanated from these activities were a highlight of this past academic year, 
allowing the Department to link its educational agenda with scholarly publishing on the 
outcomes of these various programs.  A special article on the history and outcomes of 
Interclerkship Day was published in the American Journal of Medical Quality, and an entire 
issue of Disease Management focused on the Summer Seminar “Rx for Pennsylvania.”  This past 
year also heralded the publication of Practicing Medicine in the 21st Century, our multi-authored 
edited text, which debuted during the “Medicine 2020” Dean’s program noted earlier.  This book 
became a national best seller almost immediately and has been deployed in schools of medicine, 
public health, management, business, and law.  Published by the American College of Physician 
Executives (headquartered in Tampa, Florida), Practicing Medicine in the 21st Century is the 
organization’s #1 Best Seller for this past academic year.  The Department is committed to the 
recognition that training the leaders of tomorrow is an important component of good leadership 
today. 
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Public Health Education  
 
This past year represented a watershed in the development and maturation of the TJU Masters of 
Public Health (MPH) Program.  Currently, the MPH Program is accredited by the Council on 
Education for Public Health (CEPH), with both full and part-time options leading to the MPH 
degree.  There are approximately fifty students enrolled in the program as of this writing.  This 
past year, this program was transformed from an MSPH adult learner, part-time only program to 
a more nationally recognizable MPH curriculum.   
 
This year we successfully recruited Rob Simmons, DrPH, MPH, CHES, a full-time national 
public health leader, to serve as the director of the program.  Dr. Simmons has over thirty years 
of public health experience in government, health care, private foundations and community 
health organizations and, most recently, had been a faculty member at both Drexel University 
and West Chester University.   Having been a founder and Past Board Chairperson of a number 
of health organizations such as the Healthy Delaware Foundation and the American Heart 
Association, Pennsylvania-Delaware Affiliate, Dr. Simmons is currently the President of the 
Society of Public Health Education (SOPHE), the leading national public health education 
organization in the nation. 
 
Public health and the law are topics of national interest affecting many facets of society.  
Demands for professionals with joint degrees have increased in recent years from hospitals, 
health departments, health associations, non-profit organizations and businesses.  The JD/MPH 
and MJ/MPH degrees are designed to provide the knowledge and skills required to thrive in 
health/law practice, advocacy and policy.  They will benefit a wide range of healthcare and legal 
professionals including nurses, policy makers, nursing home administrators, paralegals, 
government employees, and private practice lawyers and litigators.   
 
This year also saw the culmination of the creation of our joint program in law and public health 
with Widener University’s School of Law.  Specifically, Widener School of Law and TJU are 
now pleased to offer two joint degrees, Juris Doctor/Master of Public Health (JD/MPH) and 
Master of Jurisprudence/Master of Public Health (MJ/MPH), the only programs of their kind in 
the Delaware Valley.  One of the goals of this unique regional joint degree program is to place 
our graduates at the forefront of the policy, regulatory, and insurance issues needed for a 
successful career in public health law.  This joint degree program was officially announced in 
May 2007 at a joint press conference with the leaders of the Widener Law School and the MPH 
Program at Jefferson.  We already have successfully enrolled our first student in this new 
program! 
 
Another important aspect of the maturation of the MPH Program is the announcement of the 
Jefferson Medical College five-year joint degree program, (the so-called MD/MPH option).  
Recognizing the growing need for physician leaders who want to “make a difference” in the 
health of our communities and to develop competencies in population and community health, 
Jefferson University is now offering an MD/MPH combined degree program.  The program will 
allow medical students at Jefferson Medical College to take “a full year plus” in public health to 
obtain an MPH degree in conjunction with their medical school education.  After the second or 
third year of medical school, MD/MPH students will take a year of courses in public health that 
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include a short community-based public health experience (clerkship) and a final capstone 
research project.  The capstone may be completed in the summer of the year out or during 
elective time in the final year of medical school.   
 
We are confident that physicians and public health professionals with both the MD and MPH 
degrees will have an expansive career track available to them, including the administration of 
state and local public health departments or health centers, health insurance organizations, 
consulting activities, international programs, nongovernmental health organizations, academic 
positions with either a clinical or research focus, the pharmaceutical industry and, of course, 
clinical health practice serving our most needy populations.  With the announcement of the joint 
MD/MPH Program at Jefferson, national leaders from the AAMC came to campus in the 
summer of 2007 to review the more than forty existing MD/MPH Programs and to give us advice 
on the design and operation of our program. 
 
While Dr. Simmons will serve as the day-to-day director of the MPH Program, the Department 
Chair continues to serve as co-Chair of the MPH Steering Committee along with the Chairman 
of the Department of Family and Community Medicine at JMC.  Future plans for the MPH 
Program include the possible development of various certificates in health policy, quality, and 
patient safety.  In addition, the new Jefferson School of Pharmacy and School of Nursing will 
have formal articulation agreements with the MPH Program.  It is hoped that many of the more 
than 3,000 students on the campus of TJU will avail themselves of the opportunity to obtain an 
additional degree in public health while advancing their careers.  
The Department of Health Policy also was honored this year to be selected by the national Albert 
Schweitzer Fellowship Program to launch a regional program in the Philadelphia region.  The 
Schweitzer Fellowship provides an opportunity for graduate students in health-related disciplines 
to develop their interests and skills in community service through designing and conducting a 
year-long service project.  The Delaware Valley Schweitzer Fellows Program is the first program 
expansion site in several years, joining five previously established programs throughout the 
country.  Our service area includes Philadelphia and suburbs, Delaware, and southern New 
Jersey (Camden and Burlington counties).  While the program is administratively housed at 
Thomas Jefferson University, it is open to students throughout the service area.  In the program’s 
first year, twelve fellows were selected, and are currently engaged in their service programs, 
addressing issues such as health education, violence prevention, eliminating healthcare 
disparities, access to care for the uninsured, environmental health, and parenting skills. 
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A.  Education  
 
Overview 
 
The Department’s education team includes one faculty member, 3 project directors, 2 medical 
writers, and 3 education support staff.  We are currently recruiting for an additional senior-level 
project director, whose activities will be primarily directed to the development of special 
graduate education programs.  The team’s work is devoted to the following types of activities: 
 
• Educational programming for JMC – this includes courses, mentorships and special 
programs for medical students, residents, and fellows. 
 
• Contracted educational programs for pharmaceutical companies – these programs are 
non-product-related, devoted to education regarding specific disease states, and 
quality and patient safety issues. 
 
• Advisory Boards – these boards, which can be devoted to strategic, clinical or 
research-related topics, are organized by the team and facilitated by the Chair. 
 
• Conferences and symposia – the team is often contracted to organize, develop and 
manage professional conferences and symposia for both internal and external clients. 
 
• Continuing Education – the Department serves as the official TJU provider of 
continuing education credit for pharmacists. 
 
• Education programs for Jeffersonians – regularly scheduled programs on topics of 
interest to the general Jefferson community. 
 
• Specialized education programs – customized education programs for healthcare 
professionals, both clinical and administrative, that are focused on quality 
improvement and value-based purchasing of health benefits. 
 
• Publications – the team is responsible for the regular production of four national 
scholarly journals, a quarterly newsletter, and the creation of enduring materials 
related to some of the educational programs produced by the Department. 
 
Current Funded Education Projects 
  
The following list summarizes educational grants active in the Department of Health Policy at any time 
in the 2006-2007 academic year.  The status column indicates whether the grant remained open as of 
the end of the year.  More information on these grant-funded programs, and other education programs 
for Jefferson students, and external audiences, follows. 
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Title and Brief 
Description 
Investigators Source of Support Total Amount Status as of 
6/30/07 
Clinical Training Practica 
for Pharmacy Reps 
(Includes programs for 
clinical training in 
cardiovascular, diabetes, 
HIV, migraine, 
osteoporosis and 
respiratory; amended to 
include additional 
programs on hospital 
quality improvement) 
A. Skoufalos Merck & Co. $  750,276  
 
Open 
Practicing Medicine in the 
21st Century – editorial 
management and content 
development 
A. Skoufalos American College of 
Physician Executives 
$      8,000 Completed 
Advisory Board on 
Atypical Antipsychotic 
Medications (Meeting #6) 
D. Nash Bristol-Myers Squibb $     84,000 Completed 
Advisory Board on 
Atypical Antipsychotic 
Medications (Meeting #7) 
D. Nash Bristol-Myers Squibb $     84,000 Completed 
Bridging Care Planner 
Special Issues Board on 
the Use of Disease 
Registries 
D. Nash GlaxoSmithKline $     42,800 Completed 
Disease Management 
Colloquium  
D. Nash,  
A. Skoufalos 
Davis Wright Tremaine $     25,000 Open; will 
renew for 
2008 
Rx for Pennsylvania – 
Healing the Healthcare 
System Symposium  
A. Skoufalos Pennsylvnia Department 
of Aging 
$     67,200 Open 
Core I and II Vaccine 
Training 
D. Nash GlaxoSmithKline $     33,400 Completed 
Health Information 
Technology Advisory 
Board (Meeting #3) 
D. Nash InterComponentWare $     75,000 Completed 
Health Information 
Technology Advisory 
Board (Meeting #4) 
D. Nash InterComponentWare $     75,000 Open; 
renewing for 
Meeting #5 
Education Series on 
Evidence-Based Medicine 
D. Nash, 
A. Skoufalos 
Ortho McNeil 
Pharmaceuticals 
$     54,000 Completed 
Medicine in 2020: 
Focusing the Vision of 
Medical Education  
D. Nash JMC Dean’s Office $     52,000 Completed 
Disease Management 
(Journal) 
D. Nash Mary Ann Liebert $     42,000 Open; 
renewing for 
an additional 3 
years 
American Journal of 
Medical Quality 
(Journal)  
 
D. Nash American College of 
Medical Quality 
$     98,100 Open 
12 
  
 
Title and Brief 
Description 
Investigators Source of Support Total Amount Status as of 
6/30/07 
P&T  
Biotechnology Healthcare 
(Journals) 
D. Nash Medi-Media $  120,000 Open 
Interclerkship Day 
Program 2007 
D. Nash JMC Dean’s Office $     50,000 Completed; 
renewing 
Day in the Hospital 
Pharmacy Training  
A. Skoufalos Merck & Co. $   213,500 Open 
Advisory Board on 
Diabetes and Medicare 
Part D 
D. Nash Novo Nordisk $   118,000 Completed 
Advisory Board on 
Creating a New Prevention 
and Wellness Service 
Model 
D. Nash US Preventive Medicine $   375,000 Open 
Quality Improvement 
Roundtable Discussion 
with Publications 
A. Skoufalos Eli Lilly & Co. $   270,000 Open 
Leadership Strategies for 
Quality and Performance 
Improvement Symposium 
D. Nash Premier/CareScience $     40,000 Open 
Supplement to AJMQ re 
Managing Complex Co-
Morbid Conditions 
D. Nash,  
A. Skoufalos 
Schaller-Anderson $     30,000 Completed 
Supplement to Disease 
Management re DMAA 
Obesity Summit 
D. Nash, 
A. Skoufalos 
Disease Management 
Association of America 
$     30,000 Open 
Supplement to Disease 
Management re Chronic 
Care at the Crossroads 
A. Skoufalos Intel Health Group $     30,000 Open 
CME Program “21 
Strategies to Survive in the 
21st Century” 
A. Skoufalos Pennsylvania Academy 
of Family Physicians 
$     15,000 Open 
Supplement to Disease 
Management re Prevention 
A. Skoufalos US Preventive Medicine $     30,000  
DM Audioconference – 
Variations in Healthcare: 
A Conversation w/Jack 
Wennberg 
D.  Nash Davis Wright Tremaine $       5,500 Completed 
Health Policy Forums – 
unrestricted educational 
grant to support costs 
D. Nash Pfizer  $       5,000 Open 
Newsletter Series on 
Migraine (Pharmacy 
Credit) 
A. Skoufalos INCE $       8,000 Open 
Emergency Preparedness 
Training (Pharmacy 
Credit) 
A. Skoufalos Philadelphia Medical 
Reserve Corps 
$       8,000 Completed 
TOTAL   $2,595,776  
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1. Medical Students  
 
a. Interclerkship Day: In January 2007, the Department organized and presented the 4th JMC 
Interclerkship Day program, Improving Patient Safety, featuring two nationally prominent 
experts: John J. Nance, JD, founding board member of the National Patient Safety Foundation 
(NPSF) and aviation safety expert, and Judith A. Owens, MD, MPH, Director of the Pediatric 
Sleep Disorders Clinic at Hasbro Children’s Hospital at Brown University School of Medicine 
and Chair of the American Academy of Sleep Medicine’s Sleep, Alertness and Fatigue 
Education in Residency (SAFER) Task Force. The program addressed many of the barriers to 
incorporating patient safety and quality improvement tools in the inpatient setting, prompted 
students to think of ways in which the culture at Jefferson could be changed to promote greater 
patient safety, and emphasized the need to utilize a systems approach with full support from 
leadership, management, providers, and staff to comprehensively address and reduce problems 
and errors. Outcomes of the program were published in the American Journal of Medical 
Quality.  
 
b. Summer Internship: The Department continued to serve as a training site for medical 
students who completed the freshman year and were selected to participate in the Dean’s summer 
internship program. This year’s (2006) student, Kathryn (Karisa) Walker, researched topics in 
medical education and health policy, which culminated in her co-authorship with the Chairman 
of a chapter in the multi-author text, Practicing Medicine in the 21st Century. 
 
c. Academic Year Internship: The Department has gained a reputation as a training site for 
medical students who are completing requirements for the MBA program. The Department 
welcomed Eric Moskowitz and Jeffrey Clough, both Jefferson students participating in the joint 
MD/MBA program with Widener University, as academic interns. Eric and Jeff participated in 
research and education projects (e.g., the online residency training program sponsored by the 
American Headache Society; several medical advisory boards), attended the national MD/MBA 
conference, and worked to rejuvenate student interest in the joint program.  They were also co-
authors of different annotated bibliographies that were published in the American Journal of 
Medical Quality.  Eric co-authored the article on graduate medical education competencies; Jeff 
co-authored the article on health care governance for quality and safety. 
 
d. Policy Electives  
 
• HPOL499 – Independent Study: In March of the JMC senior year, the Chairman 
conducts a one-month graduate-style elective in health policy. This year students read 
The Quality Solution, co-edited by the Chair and Neil Goldfarb, Vice Chair for Research. 
This book was critically reviewed by the students with the Chair’s guidance. The Chair 
also continues to serve as the faculty advisor of the JMC student club, “Physicians of 
Tomorrow.”  
 
• HPOL401 – Introduction to Health Policy: This second fourth-year elective was 
offered twice in the spring of 2007. The one-month course is taught by Neil Goldfarb and 
Laura Pizzi, Division Director of Pharmacoeconomics and Outcomes Research. It 
provides an overview of current issues in health policy, including health care financing, 
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access to care, quality and safety improvement, and technology assessment. The elective 
will continue to be offered in three tracks each year.  
 
e. MD/MBA Program: It is widely acknowledged that physician training in management skills 
must improve. Indeed, a growing body of literature specific to the physician manager is available 
and is actively tracked and contributed to by the Department. Currently 12 JMC students are 
enrolled in the unique five-year MD/MBA training program, co-directed by JMC through the 
Department of Health Policy and Widener University. This year saw the graduation of the eighth  
cohort of students from the combined degree program. Not surprisingly, the JMC MD/MBA 
students have proven to be academic standouts within both the undergraduate medical and 
graduate business curricula. The students, faculty, and administrators responsible for directing 
this program meet twice during the academic year to review progress and make plans for future 
enrollees. A research agenda regarding a longitudinal study of their attitudes, knowledge, and 
beliefs is currently underway, in collaboration with the JMC Center for Research in Medical 
Education. 
 
2. Graduate Students  
 
As noted in the “General Overview” section at the beginning of this report, the Department hired 
a Director for the Masters of Public Health program in the College of Graduate Studies, and 
continues to have a leadership role in program expansion and improvement.   Department faculty 
also teach many of the courses offered to MPH and other CGS students. 
 
a. Courses  
 
• GC515 – Quality Measurement and Outcomes Analysis in Health Care:  This 
course, cross-listed with University of the Sciences in Philadelphia, now in its sixth year, 
is led by Neil Goldfarb, Vice Chair of Research. Guest faculty are drawn from the 
Department, and the Jefferson and Delaware Valley communities.  
 
• GC650 – Economic Evaluation of Healthcare Technologies:  This course (formerly 
titled “Pharmacoeconomics”) is led by Laura Pizzi, PharmD, Division Director of 
Pharmacoeconomics and Outcomes Research and Thomas Bunz, PharmD, Research 
Instructor.  
 
• GC660 – Statistical Methods for Data Analysis:  This course was offered in the fall 
of 2006, and in the spring and summer of 2007, under the leadership of Albert Crawford, 
Assistant Professor.  Dr. Crawford was assisted by Diane Richardson, PhD, Research 
Instructor, in the fall and spring; Dr. Richardson is serving as the lead instructor of the 
course during the summer.  
 
• PH506 – Health Services Research Methodology:  This course was offered in the 
spring of 2007, under the leadership of Jennifer Lofland, PharmD, MPH, PhD. Many of 
the individual sessions are taught by members of the Department’s research staff and 
other guest faculty.  Kathryn Kash, PhD, will assume leadership for the course for its next 
offering in spring of 2008. 
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• PH508 – Health Policy: An International Perspective:  This new course on 
international policy, developed by Vittorio Maio, PharmD, MPH, Research Assistant 
Professor of Health Policy, in collaboration with Daniel Louis, MS, Managing Director 
of the Center for Research in Medical Education, was offered for the first time in Spring 
2007.  
 
A proposal was accepted for a new course in the MPH program, Introduction to GIS Mapping, to 
be led by Elaine Yuen, PhD, beginning in 2008. 
 
 
3. Fellows  
 
a. Outcomes Research Fellowship Programs  
 
The Department continues to serve as a training site for outcomes research fellowships. During 
2006-2007, fellowships were sponsored by Ortho-McNeil Janssen Scientific Affairs, LLC, and 
GlaxoSmithKline.  Fellows who participated in this program are PharmD- or MD-trained 
clinicians. Collaborations such as these have resulted in numerous published studies and posters 
for presentation at national meetings. In June 2007, the Chair hosted the Seventh Annual 
National Fellowship Advisory Council, a group of more than 29 former Department fellows, in 
Philadelphia, PA. The National Advisory Council provides overall strategic direction for the 
fellowship program. Alumni of the fellowship program are often a source of research support for 
the Department.  
 
b. Delaware Valley Schweitzer Fellows Program  
 
As discussed earlier, since September 2006, the Department has served as the home of the 
Delaware Valley Schweitzer Fellows Program (DVSFP). This prestigious program provides 
stipend support to students in degree-conferring programs who have an interest in community 
service. In this, the inaugural year of the program, 12 Fellows were selected from academic 
programs in the region and they are actively implementing their projects in Philadelphia and its 
suburbs, Southern New Jersey, and Delaware. More information on the DVSFP and current 
projects is available at www.schweitzerfellowship.org/features/us/del.   
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4. Residents  
 
a. Residency training  
 
The Chair continues to be involved in clinical training through his outpatient practice activities 
and time spent on the teaching service at TJUH. Dr. Nash serves as an advisor to the Residency 
Program Directors in Internal Medicine as they plan their pay-for-performance program. He and 
other Department faculty have been featured speakers during several of the Family Medicine and 
Internal Medicine residency noon conference programs.  
 
The Department of Medicine has created 8 career pathway tracks for residents in Internal 
Medicine; these are detailed in a newly published brochure, “Personalized Career Pathway: An 
individualized approach to training in Internal Medicine for the new Millennium.”  The Chair 
serves as the coordinator for the MBA/MPH/Robert Wood Johnson Clinical Scholar track. 
 
One of the Department’s joint education/research projects involved refining an online training 
program on headache for neurology residents.  The Department helped to refine the content so 
that it was aligned with all of the GME competencies.  Residents from Jefferson’s neurology 
program were involved in some of the pilot testing of items prior to the full project launch.   
 
 
5. Other Educational Programs and Audiences 
  
Pharmaceutical Training  
 
Many area pharmaceutical companies are interested in providing both basic and advanced 
training for their sales and national account representatives on various topics, including specific 
disease states, improving patient safety, and issues surrounding quality improvement.  By 
developing non-product-related educational programs, the Department is contributing to the 
transformation of the detail sales force consistent with evolving ACCME policies.  This is a key 
cultural change, and is crucial in creating an appropriate atmosphere and relationship between 
academic medicine and pharma.  The Department is pleased to be at the forefront of fostering 
innovation and change.  Below is a list of the various programs offered by the Department during 
the 2006-2007 academic year. 
 
a. Asthma: Merck sales representatives and product managers completed a full-day clinical 
practicum on asthma and allergic rhinitis. As part of this program, the participants toured the 
pulmonary lab, experienced pulmonary function tests, were shown laboratory specimens, and 
interacted with primary care physicians and specialists. This program has been offered seven 
times during the 2006-2007 academic year; additional dates are planned for the remainder of 
2007 and into 2008.  
 
b. Cardiovascular: This is another in a series of full-day clinical practicum training programs for 
Merck sales representatives and product managers. Participants receive a combination of didactic 
and experiential training (including demonstrations in the cardiac catheterization lab and 
ultrasound), have the opportunity to interact with primary care physicians and specialists, and are 
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afforded a question and answer period. The program familiarizes the participants with the 
diagnosis, treatment and management of cardiovascular disease. It was offered twice during the 
2006-2007 academic year.  
 
c.  “Day in the Hospital”: This program, piloted in August 2006, was designed for Merck sales 
representatives who call on hospital pharmacies. The goal is to provide an overview of: hospital 
governing structure and procedures, the role of the hospitalist, how the P&T committee is 
organized and reviews items for consideration, and how a hospital pharmacy is structured to 
support and coordinate patient care.  The program was offered four times during the 2006-2007 
academic year, and is scheduled to continue through 2007 and into 2008. 
 
d. Diabetes: Merck sales representatives and product managers completed a full-day clinical 
practicum on diabetes. As part of this program, the participants were shown laboratory 
specimens and interacted with primary care physicians, specialists, and related health 
professionals. The program placed special emphasis on the team approach to management and 
treatment. This program has been offered a total of six times during the 2006-2007 academic 
year; additional dates are planned for the remainder of 2007 and into 2008.  
 
e. Evidence-Based Medicine - Fall 2006 Educational Series: An educational program was 
designed for a variety of special audiences for Ortho-McNeil Janssen Scientific Affairs and other 
affiliated departments of Johnson & Johnson (J&J) on the topic of evidence-based medicine. 
Johnson & Johnson has recognized that the changing health care landscape has a tremendous 
impact on its business model, and wanted to ensure that its employees, especially those working 
in clinical trials and pharmaceutical marketing, have a good understanding of how it works.  
A two-part, half-day session was delivered twice (once in Raritan and once in Titusville). Over 
100 participants attended an educational program that featured the Chair and the Vice Chair for 
Research. The sessions were videotaped and archived to be made available to employees from 
other J&J locations who were unable to attend.  Two DHP-edited texts, The Quality Solution and 
Economic Evaluation in US Health Care: Principles and Applications, were among the required 
reading preparation for the program participants.  
 
f. HIV: Merck sponsored a program for their specialty reps in the infectious disease and vaccine 
areas on HIV.  The two-day program included presentations from clinicians and representatives 
from a local AIDS support program, so that participants were able to understand the full impact 
of the disease from both a clinical and social perspective.  The program was offered twice during 
the academic year. 
 
g.  Migraine: Merck sales representatives and product managers completed a full-day clinical 
practicum on migraine. The participants toured the headache center and interacted with primary 
care physicians and a variety of specialists (i.e., neurologist, emergency medicine, OB/GYN, and 
psychiatrist) who treat patients with migraine. The program was offered in January 2007.  
 
h. Osteoporosis: This program was designed for newly hired Merck sales representatives, with 
no prior health care experience, who call on those primary care physicians referring patients to 
rheumatology and/or gynecology. The goal was to prepare the sales representatives for the 
complex and dynamic health care environment by providing hands-on experience and helping 
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them to gain understanding where products fit and how they are utilized. Participants were 
exposed to the hospital organization, the responsibilities of the key personnel within each 
division, and the interdisciplinary approaches to diagnosis of disease states. The program was 
held twice during the academic year. 
 
i.  Hospital Quality Improvement: Merck requested a program for their regional sales forces (to 
be rolled out nationwide) on the topic of hospital quality improvement.  The sponsors objective 
was to educate their account representatives on the various quality improvement initiatives, 
reporting requirements and pay for performance programs being rolled out by health plans and 
the federal government.  The program included both live and videotaped sessions by the Chair 
that provided an overview of the national quality landscape.   
 
j. Vaccines: GlaxoSmithKline sales representatives practiced their detailing skills with a 
simulated medical office team composed of a family practitioner, nurse, office manager, and 
pediatrician. This experience provided the representatives with insight into the different roles and 
perspectives of the various members within an office setting. During the second phase of their 
training, the sales representatives met with an immunization specialist from the Pennsylvania 
Department of Health, who discussed how vaccines are used in the Philadelphia area from a 
public health perspective (child and adult schedules). An infectious disease specialist presented 
case studies on the use of vaccines in the hospital.  This combination of programs was offered 
twice in the 2006-2007 academic year.  
 
 
Advisory Boards 
 
Due to the Department’s specialized capabilities, and the Chair’s national reputation as an expert 
in the area of quality, the Department is often called upon to organize advisory boards.  Through 
our efforts in reruiting and facilitating these boards, the Department is able to expand its already 
considerable national network, contribute to its research portfolio, and enhance both the 
Department’s and Jefferson’s reputations.  The boards are generally categorized as clinical, 
strategic, or technical (or some combination) and can cover a variety of topic areas, such as 
wellness and prevention, health information technology, and pharmacoeconomics.  Below is a 
list of advisory boards organized by the Department and facilitated by the Chair in the 2006-
2007 academic year. 
 
a. Adherence and Persistence: The Department of Health Policy and GlaxoSmithKline founded 
The National Advisory Board on Adherence and Persistence, the purpose of which was to draft a 
list of recommendations regarding adherence and persistence in order to develop a consensus 
statement on future directions for related health care research and policy. Subsequent to The 
National Advisory Board meeting were five Special Issues Boards, regionally convened groups 
of employers who addressed the issues associated with adherence and persistence in their 
employee populations. The final product of the five board meetings is a one-hour CD, hosted by 
the Chair, featuring national policy experts in the area of adherence and persistence. The CD was 
advertised for purchase in various human resources trade publications in the spring of 2007, and 
was distributed to all attendees at the 2007 Disease Management Colloquium.  
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b. Atypical Antipsychotics: The Department serves as host, and the Chair as facilitator, for the 
ongoing Atypical Antipsychotics Advisory Board supported by Bristol-Myers Squibb. The 
Board, composed of nationally recognized experts in the fields of psychiatry, Medicaid, and 
managed care, met twice during the course of the academic year.  The Board convened for the 6th 
time in October 2006 and the 7th 
 
time in April 2007 to address new findings in the field.  They 
are scheduled to meet again in the spring of 2008. 
 
c. Diabetes and Medicare Part D: The Department serves as host, and the Chair as facilitator, 
for the Changing Diabetes Initiative Advisory Board supported by Novo Nordisk. The Board 
met for the first time in October 2006, when it brought together various stakeholders with an 
interest in how the advent of Medicare Part D would affect dual-eligible beneficiaries.  The 
Board included clinicians, policy experts, and representatives from CMS and managed care.  The 
Department developed a risk assessment tool for use by Novo Nordisk in identifying individuals 
at increased risk of developing diabetes.  The Board was scheduled to meet again in the fall of 
2007, and again in 2008. 
 
d.  Disease Registries: The Department hosted a special issues board on the use of disease 
registries to improve care coordination and management in physician practices, facilitated by the 
Chair.  The board was sponsored by GlaxoSmithKline’s Outcomes Research Group. The meeting 
was held in Philadelphia in September 2006; no follow-up meeting has as yet been scheduled. 
 
e.  Health Information Technology: The Department serves as host, and the Chair as facilitator, 
for the ongoing National Advisory Board supported by the US branch of InterComponentWare 
(ICW), a technology company headquartered in Germany. The Board, composed of nationally 
recognized experts in the field of health information technology, met in November 2006.  The 
Board planned to meet with the parent company’s International Advisory Board at a special 
summit in Berlin in July 2007 to address new findings in the field.   
 
f.  Prevention and Wellness: In December 2006, the Department hosted, with the Chair as 
facilitator, the second meeting of the National Advisory Board for US Preventive Medicine 
(USPM).  USPM is working to create a new model to deliver preventive and wellness care, and 
has assembled a diverse group of stakeholders and experts.  The proceedings from the group’s 
first meeting were chronicled in a special supplement to Disease Management.  The group is 
rolling out a prototype model this fall, and hopes to schedule its 2008 meeting soon. 
 
g.  Quality Improvement: In March 2007, the Department convened a special roundtable 
discussion group to review various quality improvement strategies that affect the general national 
landscape and both the hospital and ambulatory care settings.  The program was sponsored by Eli 
Lilly & Company, and was an invitation-only event.  The goal was to provide a forum for some 
of the pre-eminent experts in quality to discuss and review specific projects and programs that 
could serve as models.  The connection with the participants from the forum has already led to 
the development of proposals for research in the areas of error reporting, EMR implementation, 
and implementation of quality improvement projects.   
 
The ultimate outcome of the forum was to create articles that would comprise four separate 
supplements to the Health Policy Newsletter, and be disseminated to interested groups across the 
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country.  During the summer, the medical writing staff and the Vice Chair for Education are 
working with the participants to develop their articles and create the pilot issue.  The initial 
supplement was scheduled to be published in September 2007, with the remainder scheduled for 
publication in December 2007, and March and June 2008.  This type of educational forum, and 
the resulting dissemination of enduring materials to a broad audience, has the effect of spurring 
discussion and encouraging the examination of data that has the potential to transform quality 
improvement initiatives nationwide. 
 
 
Conferences and Symposia 
 
The Education staff have been called upon by internal and external clients to create local, state 
and national professional conferences and symposia, providing expertise in content development, 
faculty recruitment, marketing, and conference management services. 
 
a.  Medicine 2020:  Focusing the Vision of Medical Education: The Department was asked to 
organize this special conference, sponsored by Dean Thomas J. Nasca, to provide a national 
forum to discuss the ways in which we must reform the education of medical students to meet 
the demands of the 21st century.  Speakers from Stanford, AAMC, ABIM and other key 
stakeholders spoke to an audience of over 200 participants.  Copies of Practicing Medicine in the 
21st Century were provided to the attendees. 
 
b. Disease Management Colloquium: For the fourth consecutive year, the Department hosted 
the Disease Management Colloquium, the only executive education course on the role of disease 
management in Medicare, Medicaid, health care cost efficiency, quality and medical error 
reduction. The program has become so popular that it has been permanently moved off the  
Jefferson campus to the Hyatt Penns Landing Hotel. Over 300 attendees (including several from 
foreign countries) participated in the three-day program that featured more than 60 national 
experts in disease management. The Disease Management Editorial Board met for its annual 
dinner and business meeting during the second day of the symposium.  
 
c. Rx for Pennsylvania: Healing the Healthcare System: The 13
th 
Annual Summer Seminar is 
focused on Governor Rendell’s proposed health care reform program, “Rx for Pennsylvania.”  
The program is sponsored by the Pennsylavnia Department of Aging, and features Secretary of 
Aging Nora Dowd Eisenhower and Rosemarie Greco, Director of the Governor’s Office of 
Health Care Reform. Over 225 participants from across Pennsylvania and the region plan to 
come together to discuss the impact of our increasing aging population on health care access, 
clinical practice, and service delivery models.  One of the highlights of the program is a 
roundtable discussion on how to bridge the gap between the vision and implementation of the 
reform program.  The roundtable features representatives from various stakeholder groups 
including consumers, payers (government and private), and providers (Pennsylvania Academy of 
Family Physicians and Main Line HealthCare).  The panel discussion will be moderated by the 
Chair and preserved in the form of a podcast (available for download from the DHP web site).  
WHYY will capture the roundtable session on videotape for later broadcast on their Wider 
Horizons network.  Last but not least, the December 2007 issue of Disease Management will 
feature articles on the topic authored by the principal speakers from the program. 
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Continuing Education Programs 
 
Collectively, the members of the Education team have many years of professional and practical 
experience in designing and implementing continuing education programs for a variety of 
audiences.   
  
a. Continuing Medical Education: The Department continued its outstanding collaborative 
relationship with the Office of Continuing Medical Education. The Department continues to 
provide the second-highest-grossing CME activity within JHS. During the 2006-2007 academic 
year, the Vice Chair for Education was appointed to serve on the JMC-CME Committee.  
Further, in keeping with the new initiative to provide CME credit for quality improvement 
efforts, the Department is helping to introduce this effort within JUP-CCC.  
 
b. Continuing Pharmacy Education: The Department serves as an approved provider of 
continuing education for pharmacists through the American Council on Pharmaceutical 
Education (ACPE). The Department is the only approved provider on campus and works closely 
with other Departments to maximize their continuing education programs. The Department was 
successfully reaccredited to provide CE to pharmacists.  
 
 
Education Programs for Jeffersonians 
 
As part of the Department’s education mission, we endeavor to provide a variety of regularly 
scheduled programs of interest to the campus community at large, with a focus on policy issues. 
 
a. Health Policy Forum: The Department continued to conduct the Health Policy Forum, now in 
its 17th year. The Forum has become a fixture in the scholarly life of the University. It meets on 
the second Wednesday morning of every month (except July and August) and provides an 
opportunity for all Jeffersonians and area professionals interested in health policy to congregate 
and share their research experiences. This past year, the Department sponsored such guests as: 
Tom DeSanto, JD, Executive Vice President of Aloysius Butler & Clark; James O’Hara, Director 
of Policy Initiatives and the Health and Human Services Program at Pew Charitable Trusts; 
David Smith, PhD, Professor of Risk Insurance and Healthcare Management at Temple 
University; Warren Ross, MD, Senior Client Partner for Academic Health Center Practice at 
Korn/Ferry International; Charles Elson, JD, Director of the Weinberg Center for Corporate 
Governance at the University of Delaware; Nora Dowd Eisenhower, JD, Secretary of the 
Pennsylvania Department of Aging; Richard Miller, MBA, President and CEO of Virtua Health; 
and Jeff Gruen, MD, MBA, President of Revolution Health Group.  Total attendance at the 
Forum exceeded 350 participants in the past year.  
 
b. Grandon Lecture: John G. Reiling, PhD, MHA, MBA, President and CEO of Safe by Design, 
delivered the 16th Annual Raymond C. Grandon Lecture in May 2007. His presentation, “Patient 
Safety:  The Impact of Facility Design” detailed the ways in which patient safety can be 
improved by “designing out” the errors, such as by ensuring there are handwashing facilities in 
each patient room and placing nursing stations close to patient areas.   
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The Jefferson community had specialized access to Dr. Reiling for the entire day of his visit. The 
morning began with an invitation-only Ambulatory Care Breakfast Summit with the leadership 
of Jefferson University Physicians, where Dr. Reiling was featured at a roundtable discussion.  
The meeting’s agenda focused on creating a culture of safety and a review of the plans for 
Jefferson’s new Ambulatory Care Center.  After the summit, Dr. Reiling met with members of 
the Department to discuss patient safety and ways to reduce medical errors.  He then delivered 
the Grandon Lecture, and answered questions from the audience and from the members of the 
Jefferson reactor panel.  The Chair has been appointed to the Boca Raton Community Hospital’s 
National Advisory Council, a group created by Dr. Reiling to assist him in designing the “safest 
hospital in the nation,” in Boca Raton, Florida. 
 
 
Specialized Education Programs 
 
a.  Accelerating Best Care in Pennsylvania: See “General Overview” section above for 
information on this hospital quality and safety improvement program. 
 
b.  American College of Physician Executives (ACPE – Tampa, FL): The Department was 
involved in the further refinement of “Interact,” the web-based course sponsored by the 
American College of Physician Executives (Tampa, FL). The Chair produced and filmed an 
updated two-CD course, titled “The Three Faces of Quality,” for physician executives 
throughout the United States. It continues to be offered six times per year in an asynchronous 
fashion through a secure web site with streaming video and simultaneous full printed text of the 
lectures. The online classroom experience is facilitated by the Chair and two additional 
nationally prominent faculty members. Comprehensive surveys indicate that this course is very 
well received.  
 
c.  College for the Advanced Management of Health Benefits: In collaboration with the 
National Business Coalition on Health and the HealthCare21 Business Coalition in Tennessee, 
the Department launched the College for Advanced Management of Health Benefits (CAMHB) 
in 2004.  CAMHB is designed to train employee benefit managers, other corporate executives, 
brokers and benefits consultants on the concepts of “value-based purchasing” of health benefits.  
A value-based approach to buying benefits is central to the DHHS vision for the future of health 
care articulated by Secretary Leavitt, and is being incorporated into reimbursement systems for 
CMS (Medicare and Medicaid) and other large purchasers and payers.  Three three-day CAMHB 
sessions were held over the past academic year, training over 100 participants.  Evaluation 
activities being conducted by the Department’s research staff demonstrate a positive response to 
the program content and concepts, and significant change in benefits policies within the 
participants’ organizations. 
 
d.  Pennsylvania Academy of Family Physicians: The Pennsylvania Academy of Family 
Physicians (PAFP) approached the Department early in 2007 to create a special CME program 
that could be taken “on the road” for their members around the state.  The program, “21 
Strategies to Survive in the 21st Century,” is based on the recently published text, Practicing 
Medicine in the 21st Century, and was delivered at ten different locations throughout 
Pennsylvania.   The Vice Chair for Education and Drs. Jacoby and Sarfaty, two DHP faculty 
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members, collaborated with PAFP to develop the program objectives, create the slide deck, and 
coordinate content delivery between the two designated presenters (one from PAFP, one from 
DHP).   
 
 
Enduring Materials (Proceedings of Education Programs) 
 
In addition to overseeing the production of publications of the Department, which are addressed 
in a separate section of this report, the education team is responsible for developing and 
preparing manuscripts based on some of the programs delivered during the course of the year. 
Supplements, newsletter articles, monographs, and journal articles serve as enduring materials 
for the proceedings of key meetings (e.g., Preventive Medicine:  A “Cure” for the Healthcare 
Crisis, U.S. Preventive Medicine Advisory Board Meeting, Disease Management, 
November/December 2006; and Building Bridges:  Managing Challenging Complex Co-Morbid 
Conditions, Proceedings from a Symposium at Schaller-Anderson, American Journal of Medical 
Quality, March/April 2007), clinical discussions of new treatments, and presentations of national 
policy issues. The Department has three medical writers who regularly attend local, regional, and 
national meetings to report on important issues and trends.  
 
Future of Educational Programs  
 
The Department will continue to offer a diverse range of programs across the spectrum of the 
medical education curriculum, and to other regional and national audiences. Several 
opportunities for increased involvement and support of JMC’s efforts exist and will continue to 
be explored.  
 
On the undergraduate level, the Interclerkship Day on patient safety was extremely well received 
and the program is being revised for January 2008. We recognize that medical students would 
benefit from more exposure to non-traditional subjects such as health policy, quality 
improvement, error reduction, evidence-based practice, and public health. We will work with 
JMC leadership to explore other opportunities, such as assuming responsibility for an additional 
Interclerkship Day, perhaps with other disciplines (nursing, pharmacy, OT/PT). 
 
Opportunities also exist to expose residents to these same topics and issues on the graduate 
education level. Leadership, especially as it applies to implementing quality improvement and 
patient safety initiatives, is a key subject area to explore at the graduate level.  The Department is 
committed to exploring opportunities to improve education at all levels in order to better prepare 
physicians for the coming changes in health care.  
 
Finally, we will continue to support the Medical College’s faculty development program by 
offering support for training programs on policy, performance measurement and improvement 
and other relevant topics.  
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B.  Research
Overview 
The Department’s research team includes 12 faculty members, 10 research support staff, and 2 
full-time research fellows.  At any one time, this team is engaged in approximately 30 projects.  
The team is organized into four main divisions: 
• Quality measurement and improvement – looking at issues related to health care quality 
and safety, including development of new measures, and evaluation of programs intended 
to improve quality and safety.  This team also oversees ambulatory care performance 
measurement and improvement for the Jefferson University Physicians (JUP) outpatient 
practices. 
• Health services and health policy research – evaluating interventions and policies 
addressing health care access, delivery, and finance, and disseminating best practices. 
• Public health education and research – developing opportunities for MPH students to gain 
research experience, developing an agenda for community-based research, and 
overseeing the Delaware Valley Schweitzer Fellows Program. 
• Pharmacoeconomics and outcomes research – conducting economic evaluation of new 
drugs and devices, developing economic models, and measuring outcomes associated 
with pharmaceutical interventions. 
The Department’s research mission, as noted in the introductory section of this report, is broad, 
and encompasses seeking solutions to many of the challenges facing the health care system in the 
United States and overseas.  Within this generalist framework for research, specific areas of 
expertise which are represented among the research faculty and staff include (but are not limited 
to): 
• Conducting pharmacoeconomic evaluations, including development of economic models 
• Development and evaluation of disease management programs and other health 
management interventions 
• Designing and testing quality and safety measures and measurement systems 
• Evaluating the impact of health information technology and IT interventions 
• Conducting retrospective analysis of large claims and health record datasets, and 
national research datasets 
• Collaborating with community-based organizations to evaluate the impact of policies 
and programs on client care and health outcomes 
• Measuring health outcomes, including employee productivity, in the workplace, and 
designing effective value-based benefit strategies 
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• Evaluating the impact of educational programs on providers, policy decision makers, and 
consumers 
 
In order to further foster the Department’s research mission in the past academic year, two  
research interest groups were formed: 
 
• Cancer Policy and Outcomes Interest Group: was formed to promote research on the 
policy dimensions of cancer care.  Tying in closely with the University’s strategic plan, 
the group’s goal is to work with cancer researchers at Jefferson and in the broader policy 
environment to conduct research and disseminate findings, so as to improve the quality 
and cost-effectiveness of cancer care.   Areas of interest include, but are not limited to: 
o The cancer patient’s needs from and perceptions of care 
o Improving access to and effectiveness of cancer screening and prevention  
o Measuring and improving outcomes of cancer care 
o Assessing the direct and indirect (productivity) costs of screening and treatment 
interventions   
 
The group seeks to apply this expertise to cancer policy questions such as: 
o How does cancer impact on quality of life for the patient and family members? 
o How can patient and family member decision making among treatment or 
screening options be facilitated? 
o How can pain management and palliative care be improved? 
o Which screening, diagnosis, and treatment interventions are most cost-effective?  
• Employer Research Interest Group: The Department’s employer research group 
promotes research and education opportunities for employers who provide healthcare 
benefits to their employees. Our goal is to partner with employers, employer coalitions, 
and the health plans that administer employer-sponsored benefits in research activities 
that will improve the quality, cost-effectiveness, and value of healthcare. Our areas of 
interest and expertise include, but are not limited to: 
o Providing education about value-based purchasing  
o Measuring and managing employee productivity 
o Evaluating health and disease management programs in employer settings 
 
The Employer Research Group seeks to apply the Department’s knowledge and expertise 
to answer employer related questions such as: 
o How do I know if my organization is maximizing value in benefits purchasing? 
o How do I evaluate and monitor the degree to which certain disease states and 
expensive treatments impact the health and productivity of my employee 
population? 
o How can I obtain an independent evaluation of the effectiveness of the wellness 
and disease management programs my organization currently pays for? 
o How can I encourage employees, as healthcare consumers, to become more 
engaged in health management and care-seeking decisions? 
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Two additional research interest groups are in the formative stages.  The first is a Public Health 
Research Interest Group, focused on developing the Department’s agenda for community 
partnerships and community-based research.  The Department recently began conducting an 
inventory of existing community relationships, as a starting point for this activity.  The second 
research interest group will be examining the impact of global climate change on health.  The 
group currently is examining the existing literature on the impact of climate on health and 
disease, and will seek to contribute to the body of evidence through epidemiologic and statistical 
approaches. 
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1.  Funded Project List 
 
The following table presents information on Department of Health Policy research grants that were 
active at any point during the 2006-2007 academic year.  The status column indicates whether the grant 
remained open as of the end of the academic year. 
 
Title and Brief 
Description 
Investigators Source of Support Total Amount Status as of 
6/30/07 
College for the Advanced 
Management of Health 
Benefits – A training 
program on value-based 
purchasing of employee 
health benefits 
N. Goldfarb, 
D. Nash 
Administered in concert with 
HealthCare21 and the National 
Business Coalition on Health.  
Funded by Johnson & Johnson 
Health Care Systems, 
AstraZeneca, Pfizer, Blue 
Cross Blue Shield of 
Tennessee, and Sanofi-Aventis, 
and participant registration fees 
$ 90,000 
(annually) 
Open, 
renewed 
annually.  
Will continue 
in 2008. 
Predictive Model 
Evaluation Using the 
Medicare Current 
Beneficiary Survey 
(MCBS) 
N. Goldfarb, 
V. Maio, J. 
Diamond 
(Family and 
Community 
Med), K. 
Novielli 
(Assoc Dean) 
ExcelleRx $ 47,550 Open 
Evaluation of Disease 
Management Interventions 
D. Nash, N. 
Goldfarb, A. 
Crawford, J. 
Clarke 
Healthways $350,000 Completed 
Evaluation of Patient-
oriented Interventions to 
Improve Quality of Care 
A. Crawford, 
N. Goldfarb, 
D. Nash 
Horizon Blue Cross Blue 
Shield 
$109,157 Open 
Evaluation of Online 
Continuing Medical 
Education for Physicians 
D. Nash, C. 
Sciamanna  
Graduate Education 
Foundation 
$102,000 Completed 
Economic Analysis of 
Productivity Data from the 
Topamax Trial 
L. Pizzi, J. 
Lofland  
 
Ortho-McNeil Janssen $95,256 Completed 
Development of a National 
Quality Measurement Set 
for Migraine  
N. Goldfarb, 
D. Nash, J. 
Lofland, S. 
Silberstein 
(Neurology) 
Ortho-McNeil Janssen $439,503 Open 
Cost Identification Study 
for Inpatient Candidal 
Infections  
V. Maio. C. 
Hartmann, N. 
Goldfarb, D. 
Horn 
(Infectious 
Dis) 
MediMedia/Pfizer $201,000 Completed 
Relationships between 
Changes in Glycemic 
Control and Changes in 
Diabetes Pharmacotherapy  
N. Goldfarb, 
B. Goldberg 
(Endocrin.) 
GSK $ 98,410 Completed 
28 
  
Economic Impact of 
Breakthrough Pain 
L. Pizzi  Cephalon $198,621 Open 
Measurement of 
Productivity Loss 
Associated with 
Overactive Bladder  
L. Pizzi, J. 
Lofland  
 
Watson $119,983 Completed 
Research Awards Program 
for the IAQ Instrument 
L. Pizzi, N. 
Goldfarb 
BMS $100,000 Open 
Evaluation of On-site 
Pharmacy Access for 
Community Health 
Centers 
V. Maio, L. 
Pizzi, 
N. Goldfarb 
Health Federation of 
Philadelphia 
 
$ 20,000 
Open 
Impact of Performance 
Improvement Modules in a 
Group Practice Plan 
N. Goldfarb,  
A. Crawford, 
D. Nash 
American Board of Internal 
Medicine 
$ 10,000 Open 
Impact of 
GetWellNetwork on 
Handwashing Behavior in 
Inpatient Care 
D. Nash, R. 
Jacoby 
GetWellNetwork $ 70,000 Open 
Physician Profiling and 
Appropriateness of 
Prescribing for the Elderly 
in Italy 
V. Maio Azienda Italy $ 74,351 Open 
Policy Implications of 
Non-adherence to 
guidelines and 
prescriptions 
D. Nash GSK $ 61,550 Completed 
Evaluation of the Impact 
of Soarian Workflow 
Management on Inpatient 
Operations 
N. Goldfarb, 
A. Crawford, 
D. Nash 
Siemens $ 60,000 Completed 
Economic Evaluation of a 
Stress Management 
Program 
N. Goldfarb Johnson & Johnson $100,000 Open 
Evaluation of a Web-
Based Training Program 
for Neurology Residents 
D. Nash, K. 
Kash, A. 
Skoufalos 
American Headache Society $195,098 Open 
Outcomes Evaluation of 
the Charite Artificial Disc 
N. Goldfarb Clinical Connexion $148,854 Completed 
Impact of the Charite 
Artificial Disc on Indirect 
Costs 
T. Bunz, N. 
Goldfarb, A. 
Vaccaro 
(OrthoSurg), 
J. Harrop 
(NeuroSurg) 
DePuy Spine $ 25,000 Open 
Prevalence of and 
Attitudes toward GERD in 
Minority Populations 
E. Yuen, N. 
Goldfarb 
AstraZeneca $109,372 Open 
Colorectal Cancer 
Screening Capacity and 
Insurance Coverage in PA 
R. Myers 
(Medicine), 
M. Sarfaty 
Pennsylvania Legislative 
Budget Committee 
$116,736 Completed 
Economic modeling and 
patient identification 
algorithms for candidemia 
T. Bunz, N. 
Goldfarb, V. 
Maio 
Medimedia/Pfizer $113,398 Open 
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Qualitative study of key 
opinion leader views on 
specialty pharmacy 
management 
L. Pizzi Berlex $69,156 Open 
Development of an 
economic model for 
overactive bladder 
L. Pizzi, T. 
Bunz 
Watson Pharmaceutical $25,483 Open 
Improving stakeholder 
knowledge of 
cardiometabolic risk 
N. Goldfarb, 
D. Nash 
Tricore Interactive/ Sanofi-
Aventis 
$185,000 Open 
Improving hospital quality 
for rural hospitals in 
Pennsylvania 
D. Nash, N. 
Goldfarb, A. 
Skoufalos 
Commonwealth of 
Pennsylvania/IPCC 
$400,000 Completed 
Literature review on cost-
effectiveness of diagnostic 
radiologic procedures as 
preventive screening tests 
N. Goldfarb, 
R. Jacoby 
GE Healthcare $58,267 Open 
Development of 
ambulatory care quality 
measures  
D. Nash,  
A. Crawford,  
N. Goldfarb 
West Virginia Medical 
Institute/CMS 
$97,568 Open 
Economic Impact of 
Pharmacotherapy for 
Chronic Disease 
T. Bunz, N. 
Goldfarb, D. 
Nash 
PhRMA $62,542 Open 
Total   $3,953,855  
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2.  Publications 
 
The Department’s mission to disseminate research findings and policy-relevant information to a 
national audience is fostered through the publications that are managed and edited by the 
Department, as well as the faculty’s seeking publication of its scholarly work in these and other 
peer-reviewed publications. 
 
The Department’s publication output includes four peer-reviewed journals: the American Journal 
of Medical Quality (AJMQ), the official journal of the American College of Medical Quality; 
Biotechnology Healthcare; Disease Management, the official journal of the Disease 
Management Association of America; and Pharmacy and Therapeutics (P&T).  David B. Nash, 
MD, MBA is the editor-in-chief of all four journals.  Three faculty members, Neil Goldfarb, 
Albert Crawford, and Vittorio Maio serve as associate editors of the American Journal of 
Medical Quality.  The publication list below does not include the many editorials and columns 
resulting from these efforts.  Details on each journal follow: 
 
American Journal of Medical Quality – As the national conversation regarding the 
measurement and improvement of healthcare quality and patient safety evolves, it is clear that 
AJMQ will continue to play a national leadership role.  The Chair has completed three full years 
as the editor-in-chief for the twenty-year-old peer-reviewed journal.  In this role, he presides over 
a prestigious ninety-five person editorial board, drawn from organizations across the United 
States and overseas.  AJMQ is closely affiliated with the University HealthSystem Consortium 
(UHC) in Chicago, Illinois, and several senior UHC officials also serve as associate editors of 
the journal.  This affiliation provides the journal with access to important operationally-based 
quality and safety projects from many UHC constituent members.  AJMQ recently launched a 
column devoted to the American Hospital Association-sponsored National Patient Safety 
Fellowship Program, further enhancing AJMQ’s leadership role in this important arena.  
Research Fellows in the Department also regularly contribute a peer-reviewed literature 
assessment section to AJMQ.   
 
As was noted earlier in this report, AJMQ received tremendous national press with regard to the 
special supplement devoted to the Pennsylvania-based, hospital-acquired infection report, 
significantly raising the journal’s impact factor.  Another supplement, published in the spring, 
was devoted to coordinating the management of complex co-morbid conditions.  Finally, AJMQ 
published three critically important annotated bibliographies emanating from the work of our 
medical school research assistants.  These annotated bibliographies focused on the following 
topics: governance and leadership of the healthcare system; an update on the ACGME 
competencies; and the first-ever annotated bibliography of the world’s literature focusing on the 
quality of ambulatory care.  These articles received major national attention and reprints were 
distributed to thousands of persons across the country. 
 
Biotechnology Healthcare – The Department continued to serve as the editorial home for 
Biotechnology Healthcare, a controlled-circulation publication focused on the socioeconomic 
and political issues in the burgeoning field of biotechnology, with an emphasis on the human 
genome.   It is distributed bimonthly and has a national circulation of 35,000.  A seventy-
member editorial board was assembled by the Department and includes representative leaders 
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from every sector within the biotechnology arena including, bioethics, law, the basic sciences, 
public policy, and the pharmaceutical industry.  This year editorials by the Chair focused on such 
topics as public policy for personalized medicine, the future of biologically-based 
telecommunications, and highlights from a regional biotechnology corporate incubator.  Among 
the feature articles this year was an interview with Steven McKenzie, MD, PhD, Jefferson’s Vice 
President of Research. 
 
Disease Management – The Department continued its exclusive editorial directorship of Disease 
Management, the only peer-reviewed journal in the field of chronic disease management.  The 
journal continues to be recognized through acceptance in Medline and Index Medicus.  The 
editorial board consists of more than sixty-five persons across the United States in such fields as 
managed care, the pharmaceutical industry, the disease management industry, epidemiology, and 
public health.  Disease Management is published bimonthly and reaches a paid national 
circulation in excess of 1,300.  The Chair is also a member of the Board of Directors of the 
Disease Management Association of America (DMAA), the leading national organization 
concerned with the public policy issues in disease management, which has evolved to be the gold 
standard for research in this burgeoning field.  The journal’s editorial board held its annual in-
person meeting during the DM Colloquium (a symposium hosted by the Department) in May 
2007.  Periodically, supplements to Disease Management are published under the editorial 
guidance of the Department.  This year, the following supplement was published:  Preventive 
Medicine:  A “Cure” for the Healthcare Crisis.  Clarke JL and Meiris DC. Disease Management. 
2006, Vol. 9, (Suppl) S1-S16.   
  
Pharmacy & Therapeutics (P & T) – The Department completed its eighth full year as editor 
and continuing education provider for P & T, a nationally recognized peer-reviewed journal 
concerned with all aspects of pharmaceutical use and care.  P & T has a national monthly 
circulation in excess of 60,000.  The editorial board of the journal is continuously updated, 
bringing in persons with expertise in pharmacoeconomics research and disease management, in 
addition to those with a general pharmaceutical industry background.  The Chair continues to 
write a monthly editorial for P & T.  These editorials are often reprinted elsewhere and garner 
email response on a regular basis.  Topics this past year included such areas as the British 
National Health Service NICE program, the pay-for-performance program under Medicare, and 
consumer engagement.   
 
 
Other Publications 
 
Health Policy Newsletter – The Jefferson Health Policy Newsletter is now in its sixteenth year 
of publication under the direction of the Department of Health Policy and is about to celebrate its 
20th anniversary.  The Newsletter serves as an important part of the TJU commitment to 
disseminate information on health policy locally, regionally and nationally.  The Newsletter is 
sent out on a complimentary basis to all physicians and senior administrators throughout the 
JHS.  In addition, the Newsletter has more than 26,000 subscribers worldwide and has been 
distributed at scores of national medical meetings.  Editorials from the Newsletter are often 
reprinted in other publications.  Letters to the editor demonstrate widespread readership of the 
Newsletter, especially among members of the national health policy community.  Once again, the 
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Department would gratefully like to acknowledge the support of Max Koppel, MD, MBA, MPH 
(JMC ’57) who has generously continued to provide additional resources to help defray the cost 
of the Newsletter’s publication.  The editorial board of the Health Policy Newsletter continues to 
evolve, with some individuals serving for the past fifteen years and other on-campus leaders 
being added on a regular basis.  The Newsletter editorial board meets quarterly and solicits 
contributions from across the campus and the region.  The lead editorials in the Health Policy 
Newsletter, written largely by the Chair, have covered such topics in this past year as Medicare’s 
Roadmap, professionalism and patient safety, and activating patient involvement. 
 
Value-Based Purchasing – Housed on the Jefferson Digital Commons, Value-Based Purchasing 
is a quarterly newsletter produced through the Department’s work with the College for Advanced 
Management of Health Benefits.  The newsletter provides information for employers to support 
their benefits purchasing behaviors based on issues of value and quality, rather than solely on 
cost.   
 
Weekly Policy Newsletters – The Department produces three weekly newsletters: Pharmabites, 
a summary of the week’s news in pharmaceutical development and evaluation; the HIT report, 
covering health information technology developments; and Quality Spotlight, summarizing news 
from the quality and safety improvement movements.  Content for the newsletters is generated 
by Department staff, through their scanning of news services, journals, the press, and other 
media.  The newsletters are distributed to a growing audience, including Department members, 
Jefferson faculty and administrators who collaborate with the Department, the Senior Scholar 
network, and other Department contacts who have requested being added to the mailing list. 
 
Texts – Two books, edited by members of the Department faculty in the previous year, continue 
to do well.  Economic Evaluation in US Healthcare:  Principles and Applications (by Pizzi and 
Lofland) and The Quality Solution:  The Stakeholders Guide to Improving Healthcare (by Nash 
and Goldfarb) are used as core texts in the growing TJU MPH Program on our campus. 
 
As noted earlier, during the past year the Department published the multi-authored edited text 
entitled Practicing Medicine in the 21st Century with the American College of Physician 
Executives in Tampa, Florida.  This multi-authored text was designed as a primer to prepare new 
physicians for practicing in a changing healthcare environment.  It was highlighted during the 
November 2006 dean’s conference entitled “Medicine 2020,” where all attendees received a 
complimentary copy.  A copy of the book was also provided to the entire Jefferson Medical 
College Class of 2011 during their student orientation.  This book continues to break all sales 
records of the American College of Physician Executives, as it is in use in schools of medicine, 
public health, management and law across the country.  Finally, various pharmaceutical 
companies have made bulk purchases of this book in order to disseminate it more widely to 
residency training programs across the country.  Aspects of this dissemination plan were covered 
earlier in this report.   
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12. Kash KM. Consequence-Based Learning (CBL): A Preliminary Analysis of  Outcomes. 
Presented at the 49th Annual Meeting of the American Headache Society, Chicago, IL. 
June 09, 2007. 
 
13. Kash KM. Jefferson School of Nursing ACE Day Cancer Survivor Panel Participant, 
Philadelphia, PA. August 14, 2006 
 
14. Kash KM. Psychosocial Oncology: Supportive Care for the Cancer Patient.  Medical 
Staff Education Days at Chambersburg Hospital, Chambersburg, PA. September 15, 2006 
 
15. Kash KM. The Ethical Implications of Genetic Testing for BRCA1 and BRCA2.  
IMPACT and AIDIT Meeting, Szczecin, Poland. November 29, 2006   
 
16. Kash KM. New Directions in the Psychosocial Aspects of Genetic Testing for  
Cancer. Psychosocial Aspects of Genetic Testing for Hereditary Cancer 9th  
Meeting, Manchester, UK. May 22, 2007 
 
17. Leas BF, Gagne JJ, Goldfarb NI, Rupnow MFT, Lofland MH, Hopkins MM, Nash DB, 
Silberstein S.  Assessing and Improving Migraine Care Quality:  Development 
of a Model Health Plan Quality of Care Measurement Set.  Poster presented at 
American Headache Society Annual Scientific Meeting, 2007. 
 
18. Leas BF, Gagne JJ, Goldfarb NI, Rupnow MFT, Lofland JH, Hopkins MM, Nash DB, 
Silberstein S.  Developing a Migraine Quality of Care Measurement Set.  Poster 
presented at International Society of Pharmacoeconomics and Outcomes Research 
Annual Meeting, 2007. 
 
19. Lee SP, Bunz T, Gagne JJ, Maio V, Goldfarb NI. Determinants of Total Hospital Costs 
Among Inpatients with Candidemia. 12th Annual Meeting of the International Society 
Pharmacoeconomics and Outcomes Research, May 22, 2007, Washington, DC 
 
20. Maio V, Yuen EJ, Smith KD, Louis DZ. Prescribing patterns following publication of the 
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial 
(ALLHAT) in Regione Emilia Romagna, Italy. AcademyHealth 2006 Annual Research 
Meeting, June 25, 2006, Seattle, WA. 
 
21. Pizzi LT, McIlwain M, Dahl NV. Safety of Transdermal Oxybutynin in the Treatment of 
Overactive Bladder among Patients Using Other Transdermal Medications: Results of the 
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MATRIX Study. Accepted for poster presentation at the 108th Annual Meeting of the 
American Society for Clinical Pharmacology and Therapeutics (ASCPT).  Anaheim 
California, March 2007.  
 
22. Pizzi LT, Gagne JJ, Lofland JH, Rupnow M, Smith KD, and Poston S. Effect of 
Topiramate Migraine Prophylaxis on Workplace Productivity: Results from Two U.S. 
Randomized, Double-Blind, Placebo-Controlled, Multicenter Trials. Poster presentation 
at the 48th Annual Scientific Meeting of the American Headache Society, Los Angeles 
California, June, 2006. 
 
23. Sand PK, Kelleher C, Pizzi LT, and Dahl NV. Effect of Treatment For Overactive 
Bladder on Work Productivity: Results from the MATRIX Study. Poster presentation at 
the International Urogynecological Association (IUGA) 31st Annual Meeting, Athens 
Greece, September 2006.  
 
24. Sarfaty M, Shibao F.  Addressing disparities in colorectal cancer.  American Public 
Health Association 134th Annual Meeting.  Boston, November 3-7, 2006. 
 
25. Sarfaty M, Myers R. HEDIS Measures and Changes in Screening Policies of 
Pennsylvania Insurers. American Public Health Association Annual Meeting. Nov. 5. 
Washington D.C. 
 
26. Sciamanna, CN, Adams SY, Breitbart RE, Crawford AG, Thier SL, Rimal RM, Lee 
JS, Janneck L.  Computer-tailored Messages in the Care of Type2 Diabetes.  Poster 
presented at the Society of  General Internal Medicine Annual Meeting: The Puzzle of 
Quality: Clinical, Educational, and Research Solutions, Toronto, April 25-28, 2007. 
 
27. Short J, Talati A, Maio V, Pizzi L, Lagermasini C, Goldfarb NI. Evaluation of the Impact 
of the Philadelphia Community Pharmacy Network Program. American Pharmacists 
Association 2007 Annual Meeting, March 18, 2007, Atlanta, GA 
 
28. Yuen EJ.  Meditation and Healthy Aging.  Complementary and Alternative Medicine  
for Elders.  Eastern Pennsylvania Geriatrics Society, March 22, 2007, Conshohocken, 
PA. 
 
29. Yuen EJ, Louis DZ, Cisbani L, Rabinowitz C, Maio V, Marangolo M. Using 
administrative data to assess patterns and quality of cancer care. Accepted at the 23rd 
Patient Classification System International Conference, November 2007, Venice, Italy. 
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C.  Patient Care  
 
The Department of Health Policy does not have a clinical practice base.  Dr. Nash is the only  
physician in the Department who currently sees patients, through ambulatory patient care in the 
Division of General Internal Medicine and participating in the inpatient attending 
physician/hospital service attending schedule. 
 
The Department’s participation in patient care activities is most directly achieved through our 
leadership role in performance measurement and improvement activities for the outpatient 
practices of  Jefferson University Physicians.  Dr. Nash chairs the JUP Clinical Care 
Subcommittee, and Neil Goldfarb, Vice Chair for Research, serves as JUP’s Director of 
Ambulatory Care Performance Improvement.  Additional Departmental staff working on JUP 
initiatives include: 
o Bettina Berman, RN, Project Director for Quality Improvement (funded 100% by JUP) 
o Al Crawford, PhD, MBA, MSIS, Senior Analyst (funded 50% by JUP) 
o Erin Whitesell, MPH, Junior Analyst (funded 50% by JUP) 
o Richard Jacoby, MD, Physician Advisor (provided to JUP, in-kind, by DHP) 
o Valerie Pracilio, Project Coordinator for Quality Improvement (provided to JUP, in-kind, 
by DHP) 
Departmental outcomes research fellows also participate in JUP Departmental initiatives.  
 
Among the key accomplishments of this team, in collaboration with the JUP Clinical Care 
Subcommittee and JUP Departments over the past year are: 
• Conducting performance measurement initiatives in almost all JUP Departments, on 
measures selected by the departments based on clinical relevance and interest in assessing 
and improving quality 
• Launching a JUP-wide smoking cessation initiative, in which all departments will 
incorporate an assessment of smoking history, and counseling and referral for current 
smokers, into their ambulatory care patient assessments and clinical documentation 
• Helping departments to track development of the CMS Physician Quality Reporting 
Initiative (PQRI) – a Medicare pay-for-performance initiative – and to select measures to 
report, to implement measurement, and to track progress via periodic data analytic reports  
• Helping JUP administration to develop Independence Blue Cross pay-for-performance 
program parameters, monitor JUP performance on these measures, and plan performance 
improvement initiatives which address these measures 
• Participating in planning sessions for implementation of an electronic health record in the 
JUP outpatient practices, and developing parameters for record templates, to ensure that 
quality data needed for pay-for-performance and public reporting programs are captured 
• Pilot testing the Physician Practice Patient Safety Assessment (PPPSA) in the General 
Internal Medicine practice, and developing a plan for implementation in all other JUP 
practices, in order to systematically measure and address opportunities for improving 
patient safety in the outpatient setting 
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D.  Affiliations 
 
The Department maintains a wide range of affiliations, within the Jefferson community and in 
the broader local, regional and national healthcare system.  Aspects of this work were reviewed 
in the General Overview section. 
 
Internal affiliations that bolster the mission of the Department are many and varied.  The 
Department serves as a data, analytic and education resource, and provides value-added 
healthcare consulting to Jefferson Medical College, Thomas Jefferson University Hospital 
(TJUH), and—to some extent—the Jefferson Health System (JHS).  The Chair serves as a 
founding member of the JHS Quality Council, chaired by Stanton N. Smullens, MD, the 
system’s Chief Medical Officer.  Other aspects of the consulting mission are expressed through 
the Chair’s service on various committees.  These include membership on the hospital’s 
Pharmacy and Therapeutics Committee (a position he has held for eighteen years) and chairing 
the Quality Medication Subcommittee of the P & T Committee.  The Chair also serves on the 
TJUH Clinical Performance Improvement Committee and was appointed to the TJUH PEACE 
Committee (Pharmacoeconomics and Cost Effectiveness).  These committees combine to 
represent an important operational component of the Hospital and University’s commitment to 
measuring and improving the quality and safety of medical care.  The critical contribution to the 
JUP Clinical Care Committee is covered elsewhere in this report. 
 
Other internal affiliations include the Chair’s service on the very important JMC Committee on 
Appointments and Promotions.  This has been an integral part of the Chair’s leadership 
responsibilities for JMC, especially as many new Health Policy Departmental faculty proceed 
through the appointment and promotion process.  In addition, the Chair recently was named an 
associate member of the Kimmel Cancer Center here on campus.  This is an important affiliation, 
which will continue to build our interdisciplinary research agenda.  Similarly, the Chair served 
on the Search Committee for the inaugural Dean of the Jefferson School of Pharmacy.  In 
addition, after successfully recruiting the top candidate, the Chair has been asked to serve on the 
School of Pharmacy Steering Committee and to help select its future national members.  The 
Vice Chair for Education has been appointed to the JMC CME Committee, as the Department is 
one of the top CME providers in the medical school.  Membership on this committee will 
continue to be very important to the day-to-day activities of the education division.  Finally, 
Mona Sarfaty, MD, a Department faculty member who oversees MPH program curriculum 
issues, has been appointed to the JMC Curriculum Committee, as this committee will deal with 
future issues regarding the integration of our growing MPH Program with the existing JMC 
infrastructure.   
 
The Department’s Senior Scholars Program, an important bridge between internal and external 
affiliations, continues to grow.  This program recognizes individuals who make a commitment to 
the Department to participate, in a modest way, in our ongoing research and educational 
activities.  The Senior Scholars now number over 250 persons who represent local, regional, and 
national leaders in industry and academia, all within commuting distance of the Department.  
The Senior Scholars receive regular updates via email and the newsletter on the activities of the 
Department and serve as mentors to the Fellows and junior faculty. 
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At the state level, the Department has an ongoing research affiliation with the Pennsylvania 
Healthcare Cost Containment Council (PHC4).  Dr. Nash also chairs the PHC4 Technical 
Advisory Group (TAG), a role he has had for the past twelve years.  The PHC4 has continued to 
publish statewide outcomes reports on coronary artery bypass graft surgery, the quality of care in 
HMOs throughout Pennsylvania and this year, the first ever, statewide, hospital-specific hospital-
acquired infection report.  This report was described in detail in the introductory section of the 
Annual Report.  PHC4 and the TAG regularly are featured in newspaper stories in the 
Philadelphia Inquirer, Philadelphia Business Journal and many national press outlets. 
 
The Chair maintained a large number of consultancies with firms in the private sector, especially 
those concerned with e-health and e-commerce.  For example, the DHP completed the seventh 
year of a strategic planning initiative with GE Medical Systems.  The Chair also leads the GE 
Medical Quality Improvement Consortium (MQIC), a national group of 12,000 physician 
ambulatory electronic medical record users.  Once again, this is how the Department links its 
external consulting work, research agenda and educational dissemination planning. 
 
On a national policy level, the Department has increased its participation in the debate 
surrounding the quality and safety of medical care, along with improving access.  This was 
achieved, in part, by the Chair’s personal involvement with numerous professional societies in 
the following capacities: 
 
• Continued 13th year as Chairman of the IMS (Plymouth Meeting, Pennsylvania) 
sponsored national disease therapeutic index, NDTI.  This is an internationally regarded 
physician-specific pharmacy tracking and research program. 
 
• Membership on the National Quality Forum (NQF) and the Council on Research and 
Quality Improvement.  The Chair was also appointed to direct the NQF Technical 
Advisory Panel (TAP) on guidelines for ambulatory pharmacy management for a second 
year. 
 
• Continued membership for a decade on the Board of Trustees of Catholic Healthcare 
Partners (CHP), the 10th largest nonprofit integrated delivery system in the country,  
headquartered in Cincinnati, Ohio.  The Chair continued to lead the CHP Board 
Committee on Quality and Safety.  He is regularly invited to address quality-related 
issues for many of the constituent institutions of the CHP and served on the Steering 
Committee for the annual CHP Governance and Leadership Retreat. 
 
• Continued membership on the Board of Directors of the Disease Management 
Association of America (DMAA), the major national group representing the disease 
management industry in Washington, DC.  The Chair is a member of this board in 
perpetuity as he is the editor of Disease Management, the official journal of the DMAA. 
 
• The Chair continued his role on the Medical Leadership Council (MLC) of the University 
Health System Consortium (UCH) and the MLC Executive Committee – the key group of 
physicians who help to set the quality improvement strategy for the UHC.  In addition, 
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the Chair is on the Ambulatory Quality Steering Committee of the UHC.  This year, a 
member of the Department (who is also a member of the JUP Clinical Care Committee) 
served as one of the inaugural UHC Quality Fellows, linking the quality agenda of the 
Department and of JUP with cutting-edge national training programs in this important 
arena.  Also, the American Journal of Medical Quality features a regular contribution by 
the National Patient Safety Fellowship Program sponsored by the American Hospital 
Association. 
 
• The Chair was appointed this past academic year to the Highmark Blue Cross/Blue 
Shield Corporate Board and was asked to serve on the board’s Quality Improvement 
Committee.  He will Chair this committee starting in the spring of 2008. 
• The Chair continues to serve on the CIGNA National Physician’s Advisory Committee 
(PAC).  The PAC is the only national committee whereby CIGNA receives feedback 
from practicing physicians in their network across the country. 
• The Chair was appointed as a judge for the national URAC-sponsored Best Practices in 
Consumer Empowerment and Protection Conference.  In this capacity, he served with 
others to review hundreds of submissions from across the country that promote healthcare 
quality via accreditation and certification programs. 
• The Chair was appointed to the regionally-based Purchasers Alliance for Transforming 
Healthcare (PATH) Advisory Committee.  This represents one of the very few 
regionally-based business coalition efforts to link the purchasers and providers of 
healthcare. 
Through membership and activity sponsored by such groups as the NDTI, NQF, CHP, DMAA, 
and the UHC, the Department is at the center of major national programs involved in measuring 
and improving the quality and safety of healthcare.  The local, regional and national activities of 
the Chair and members of the Department garnered a great deal of press attention this past year.  
More than three dozen stories regarding the work of the Department were in the national press, 
including two feature cover stories in the July 23-30, 2007 issue of U.S. News & World Report 
and the July/August 2007 issue of Trustee magazine.  Reprints of these cover stories are 
available from the Department. 
The Chair continued to ably represent the work of the Department and its research and education 
mission via his invited presentations across the nation.  In this past academic year, the Chair 
delivered more than thirty formal presentations to organizations outside of Pennsylvania and 
seven presentations to organizations within the region.  He also received the prestigious Elliot 
Stone Outcomes Research Award from the National Association of Health Data Organizations 
(NAHDO) during their annual meeting in December 2006, in Washington, DC. 
In the private sector, the Chair continued his board membership and consultative activities with a 
broad range of organizations.  As mentioned earlier, the Chair is a member of the Board of 
Directors of two publicly held companies.  He serves on the Board of I-Trax Corporation 
(AMEX:DMX), a disease management firm, where he also chairs the Board Nominating 
Committee.  He also continues to serve on the Board for Informedix (OTCBB:IFMX) in 
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Rockville, Maryland.  He was also named to the National Advisory Board of the TLC 
Corporation in Chicago, Illinois.  This is a privately held company recently purchased by 
Revolution Health that creates patient-specific websites during hospitalization to facilitate 
communication between patients and their relatives.  The Chair is also on the National Scientific 
Advisory Board of the Nanosphere Corporation (headquartered in Chicago, Illinois).  This 
privately held company is committed to creating path-breaking screening tests for cancer and 
other serious illnesses utilizing office-based nanotechnology screening tools.  These multiple 
private sector initiatives provide additional sources of external financial support for the 
Department, as well as relevant databases for the research mission.  All relevant conflict of 
interest forms and confidentiality statements are on file with the Office of the University 
Council. 
Implementing operational improvements in quality, safety, access and cost-effective use of 
resources is a major challenge.  As previously noted, the Chair continued to serve as a member 
of the Board of Trustees (and on the Quality and Safety Committee) of Catholic Healthcare 
Partners (CHP), the nation’s 10th largest integrated delivery system.  This past year, CHP 
published a major national strategic document outlining its commitment to quality and safety 
improvement.  CHP’s central headquarters staff in Cincinnati, Ohio continues to grow, and their 
educational programming, data analysis and leadership institute are a major credit to the 
organization’s quality agenda.  Through their important work, involving nearly 35 hospitals with 
40,000 employees, CHP can have a major impact on the national agenda for quality, safety, 
access and public accountability.   
As noted above, the Chair also serves on the corporate board of the Highmark Blue Cross/Blue 
Shield Association headquartered in Pittsburgh, Pennsylvania.  Highmark is the largest Blue 
Cross Plan in the state and has publicly announced its intent to merge with Independence Blue 
Cross in Philadelphia, creating a consolidated Blue Cross Plan for Pennsylvania.  The Chair also 
serves on the Quality Improvement Committee of Highmark and recently was asked to lead this 
committee in the next calendar year.  At the national and state level, these responsibilities give 
the Chair and the Department an opportunity to operationalize the concepts behind improving the 
quality, safety and access to medical care.   
 
E. Interdepartmental Programs 
 
As presented in the information on Education and Research activities in the sections above, the 
Department has formed many productive working relationships with other JMC and University 
Departments.  In brief, these include: 
 
• Leadership of the performance measurement and improvement activities for Jefferson 
University Physicians, through JUP’s Clinical Care Subcommittee 
 
• A project seeking to develop a national migraine quality measurement set, in 
collaboration with the Department of Neurology’s Headache Center. 
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• Assessment of incidence of breakthrough pain, including patients recruited from 
Jefferson’s Pain Center, Headache Center, Department of Neurology, Sickle Cell Clinic, 
and Division of Rheumatology. 
 
• Economic evaluation of candidemia in the inpatient setting, in collaboration with the 
Division of Infectious Diseases. 
 
• Economic evaluation of the Charite artificial disc, in collaboration with the Departments 
of Neurosurgery and Orthopedic Surgery. 
 
• Analysis of the Medicare Current Beneficiary Survey data to identify the impact of 
appropriate pharmacotherapy on patient outcomes, in collaboration with Dr. Novielli in 
the Dean’s Office, and the Department of Family and Community Medicine 
 
• Statewide assessment of colorectal cancer screening capacity and activity, in 
collaboration with the Department of Medical Oncology 
 
• Co-direction of the MPH program with the Department of Family and Community 
Medicine.  
 
• Publication of the quarterly Health Policy Newsletter, whose editorial board consists of 
members from the Dean’s office; the Jefferson Foundation; the College of Health 
Professions; the Department of Medicine; the Department of Family and Community 
Medicine; the Center for Research in Medical Education; and also includes 
representatives from across the Jefferson Health System (Einstein, Frankford, Main Line 
Health, and Christiana). 
 
• Clinical and hospital orientation training for pharmaceutical representatives, in 
collaboration with the Hospital Pharmacy. 
 
• Clinical training in diabetes diagnosis and management, in collaboration with the 
Department of Family and Community Medicine, Department of Pathology and 
Department of Endocrinology. 
 
• Clinical training regarding asthma and allergic rhinitis, in collaboration with the 
Department of  Family and Community Medicine, Department of Pulmonology, 
Department of Pathology and Department of Pediatrics. 
 
• Clinical training regarding migraine, in collaboration with the Department of  Family 
and Community Medicine, the Headache Center, Department of Neurology, Department 
of Psychiatry, Department of Obstetrics and Gynecology, and Emergency Medicine. 
 
• Clinical training in cardiovascular disease, in collaboration with the Department of 
Cardiology, and the Department of Family and Community Medicine. 
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F. Faculty 
 
The Department has continued to build a strong, well-rounded and diverse faculty.  Disciplines 
represented on the Department’s faculty include: public health, medicine, nursing, social work, 
sociology, pharmacy science, pharmacoeconomics and pharmacoepidemiology, education, health 
care management, philosophy, psychology, business administration, and statistics.  The 
Department’s faculty are well-poised to lend their collective interdisciplinary strengths to 
Jefferson’s strategic plan implementation.  As discussed above, Department faculty lead the 
Master’s of Public Health Program, teach program courses, and mentor enrolled students.  The 
Department also has been actively engaged in curriculum planning for the new School of 
Pharmacy.  Laura Pizzi, PharmD, MPH, Division Director for Pharmacoeconomics and 
Outcomes Research, participates on the core planning committee for the School, and Department 
faculty have been identified to teach courses including Introduction to Health Systems, Statistics, 
Pharmacoepidemiology and Pharmacoeconomics, and Complimentary and Alternative Medicine. 
 
 
G. Departmental Administration 
 
The administrative team for the Department includes a Department Administrator, a Grants 
Manager, an Office Manager, and two Administrative Assistants.  This staff serves the 
administrative needs of the entire Department, including the Chair and faculty, in support of our 
research and educational goals.  It manages the portfolio of over 40 grants at any one time, and 
ensures that all fiscal and compliance issues are handled appropriately.   
 
The Department Chair meets monthly with the Vice Chairs of Research and Education, and the 
Department Administrator, Office Manager, and Grants Administrator, to review financial 
reports and discuss administrative issues.  The Department Chair, the Vice Chairs of Research 
and Education, and the Department Administrator compose the Department’s “Steering 
Committee” and meet weekly to discuss strategy, staffing, new business development, and 
project management issues. 
 
During the last year, the administrative team has assumed additional responsibilities related to 
the Schweitzer fellowship program and the Department’s further involvement with the MPH 
program.  As we begin the ’07 -’08 academic year, due to shifting of personnel within the 
Department, we look forward to the hiring of a new Grants Administrator and a new 
Administrative Assistant.     
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H. Strategic Priorities  
 
The Department of Health Policy is proud of its many achievements over the past year, as 
documented in this admittedly lengthy report.  These accomplishments are the result of hard 
work and high-quality work from our faculty and staff.  We actively promote continuous work-
based learning and encourage staff members to pursue advanced degrees; currently, 10 of our 
research and education staff members are enrolled in advanced degree programs or taking 
graduate-level courses.  We will continue to promote continuing education within our 
Department, to parallel our efforts to educate other stakeholders across the health care system. 
 
As we continue to build the core faculty, we will seek to further develop disciplinary and 
demographic diversity.  One priority for the coming year is to expand the doctoral level 
pharmacist faculty within the Department, both to address the Department’s continuing work in 
pharmaceutical evaluation, and to further support the School of Pharmacy’s teaching and 
mentorship needs.   We also will continue to develop faculty with public health degrees and/or 
population health management experience in order to further support the Jefferson strategic plan.  
One challenge to the Department has been the lack of core support for faculty development; 
continued growth has occurred solely through deployment of external sources of support.   
 
Within the Jefferson community, we will continue to seek to develop research and education 
relationships with other departments and units of the University.  Our inter-departmental 
collaborations in  pharmacoeconomics and outcomes research, health services research, and 
quality improvement have directly linked our Department with the University’s strategic priority 
areas: cancer, cardiac care, neuroscience, infectious disease, and, of course, population and 
public health.  Our faculty will continue to network with clinical faculty on the Jefferson 
campus, to explore common interests and develop additional collaborations.   
 
In the broader local community we serve, we will continue to seek partnerships to improve the 
population’s health.  We will continue to make evaluation consulting services available to 
community agencies and seek grant funding to support research and education collaborations.  
Expansion of the Masters of Public Health program and the Delaware Valley Schweitzer Fellows 
Program also will help foster relationships while better serving the population’s needs.   
 
On the state and national levels, we will focus this year on developing strategies to expand our 
Department’s interaction with and influence on policy-makers, including legislators.  A key 
component of this activity will be developing effective education and dissemination strategies.  
In addition to the current portfolio of publications, we will consider how best to reach the 
legislative audience, be it through issue briefs, launching a Departmental blog, or other 
communication strategies.    
 
Another ongoing priority for the Department is to seek diversity in funding streams for research 
and education programs.  Nearly 50% of the Department’s funded work is supported by the 
pharmaceutical and biotechnology industries.  While we recognize the importance of this 
funding source, and are proud of the contributions we have made to scientific knowledge with 
industry support, we continue to believe that we have not yet fully leveraged our abilities to 
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obtain foundation and government grant support.  A priority for the coming year is to more fully 
identify foundations that support research and education programs within the scope of our 
expertise.  We will continue to conduct Internet research and consult with Institutional 
Advancement to develop grant strategies to help achieve this strategic goal. 
 
Lack of adequate infrastructure, particularly office space, is a critical issue which we will need to 
address in the coming year.  All of the Department’s current space allocation is being fully 
utilized, to the point that half of the faculty are office-sharing.   Expansion of faculty, support 
staff, and programs cannot take place unless additional space options are identified and utilized. 
 
As was mentioned earlier in this report, we are planning to expand our educational programming 
in the form of specialized advanced education programs in the areas of quality improvement, 
patient safety, and wellness and prevention.  We believe this type of offering can provide 
practical, ongoing professional development for physicians and other healthcare professionals, 
help to diversify our revenue streams, and support the future development of the University’s 
population and public health program. 
 
Finally, the Department seeks to capitalize on its intellectual resources, experience and expertise, 
and national network of Senior Scholars and other colleagues, to help the University achieve the 
strategic priorities related to population health and health policy.  To meet the challenge of 
transforming healthcare in the 21st century, we stand ready to partner with the University in 
fulfilling this vital part of its mission. 
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APPENDIX 
 
1.  Department of Health Policy Table of Organization 
 
2.  List of Departmental Senior Scholars 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Jefferson Medical College, Department of Health Policy, Table of Organization  (October, 2007)  
 
 
 
 
 
 
See attached tables for Research and Education Program tables of organization
Neil I. Goldfarb 
Vice Chair for Research 
Rob Simmons, DrPH 
Division Director, Public Health 
Education and Research 
Alexandria Skoufalos, EdD 
Vice Chair for Education 
David B. Nash, MD, MBA 
Department Chair 
Elizabeth DeBonis 
Office Manager Maxine Rosen 
Admin Assistant 
Jean Davis 
Admin Assistant 
Chanika Townsend 
Grants Manager 
David Glatter, MBA 
Department Administrator 
Laura Pizzi, PharmD, MPH 
Division Director, 
Pharmacoeconomics and Outcomes 
Research 
JoAnne Reifsnyder, RN, PhD 
Division Director, 
Health Policy and Health  
Services Research
Vittorio Maio, PharmD, MS, MSPH 
Fellowship Director 
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Jefferson Medical College, Department of Health Policy, Research Program, Table of Organization  
Joseph Yaskin 
Project Manager 
Valerie Pracilio 
Project Manager for Quality 
Improvement 
Alyson Leidy 
JMC Research Intern 
Nicole Cobb, MAOM 
Project Manager 
Coordinator, Schweitzer 
Fellowship
Neil Goldfarb 
Vice Chair for Research 
Research Assistant Professor 
Laura Pizzi, PharmD, MPH 
Division Director 
Quality of Care Research Public Health Education  
and Research  
Pharmacoeconomics and 
Outcomes Research 
Al Crawford, PhD, MBA, MSIS 
Assistant Professor 
Mona Sarfaty, MD 
Research Assistant Professor 
Erin Whitesell, MPH 
Research Analyst 
Vittorio Maio, PharmD, MS, MSPH 
Research Assistant Professor 
Fellowship Director
Thomas Bunz, PharmD 
Research Instructor 
Deborah Liao, PharmD 
Paresh Chaudhari, PharmD, MPH 
Outcomes Research Fellows 
Brian Leas, MA 
Project Manager 
 Varinder Singh, MS 
Research Analyst 
Elaine Yuen, PhD 
Research Associate Professor 
Bettina Berman, RN 
Project Director for Quality 
Improvement 
Kathryn Kash, RN, MPhil, PhD 
Associate Professor  
Richard Jacoby, MD 
Project Director 
Richard Toner 
Study Coordinator 
Diane Richardson, MS, PhD 
Project Director 
Rob Simmons, DrPH, MPH  
Division Director 
Lisa Chosed 
MPH Program Coordinator 
Health Policy and Health 
Services Research 
JoAnne Reifsnyder, RN, PhD 
Division Director 
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Jefferson Medical College, Department of Health Policy, Education Program, Table of Organization  
Alexandria Skoufalos, EdD 
Vice Chair for Education 
 
 
 
 
 
 *Shared position with Research Program 
 
 
Christina Raymond 
Project Coordinator 
Deborah Meiris 
Medical Editor 
Janice Clarke, RN 
Project Director* 
Jeannine Kinney 
Project Manager 
Melissa Horowitz 
Project Director 
Megan Hartman, MS 
Project Director 
Vacant 
Director, Special Projects 
Darlene Sheaff 
Project Coordinator 
Emily Frelick, MS 
Project Director 
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JMC Department of Health Policy    Senior Scholars      10/30/07 
 
Last Name First Name Degree Title Company 
Allen Harris PhD Principal Harris Allen Group, LLC 
Ammons  Linda Esquire  Dean  Widener University School of 
Law  
Amstutz Barbara   Executive Director  Vital Issues in Medicine  
August Yosaif    Managing Director Gilbert Tweed Associates, Inc. 
Anders Geoffrey JD, CPA, CHBC   The Health Care Group, Inc. 
Badolato David MD Founder & CEO  Life Laboratory  
Ballet Shelley   VP, Marketing  Wesley Enhanced Living  
Bankowitz Richard MD   CareScience 
Baram-
Clothier 
Evelyn 
  
Executive Director American Medical Foundation 
for Peer Review & Education 
Barr Michael MD, MBA, FACP V. P. for Practice Advocacy & Improvement American College of Physicians 
Baum J. Robert PhD Chairman, Highmark, Inc. / Associate 
Professor of Entrepreneurship 
Smith School of Business, 
University of Maryland 
Baumel Mark MD     
Berger Marc MD Vice President, Outcomes Research & 
Management/ Exec. Dir. US Human Health   
Merck & Co., Inc.  
Berman Eric DO, MS VP and Medical Director AMERIGROUP New Jersey, Inc. 
Bocuzzi Stephen PhD, MBA, FAHA     
Boland James MD, MPH, FACS 
  
West Virginia 
University/Charleston Area 
Medical Center 
Brown Steven MD Med. Dir., Contracting & Provider Networks Independence Blue Cross 
Burrus W. Clint 
  
Executive Vice President, Mgd. Markets & 
Trade Dept. 
King Pharmaceuticals, Inc. 
Cacchione Joseph MD, FACC Executive Vice President Saint Vincent Health Center 
Casale Paul MD, FACC   The Heart Group 
Casey Donald MD, MPH, MBA, FACP VP of Quality & Chief Medical Officer Atlantic Health  
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Cohen Richard PhD, FACHE President and CEO Philadelphia Health 
Management Corporation 
Cohen Hedy RN, BSN, MS Vice President Institute for Safe Medication 
Practices 
Connors Barbara DO, MPH Medical Officer, CMS Region III Center for Medicare & Medicaid 
Services 
Cross James MD National Medical Director Aetna, Inc. 
Cuerdon Timothy PhD Health Systems Specialist  Office of Quality and 
Performance  
Cusack Susan  RN, MSN, MBA, CHE     
Cutler J. J.   President & COO  Lindi Skin  
d'Arville Carolyn PhD., MS  Director, Professional Liaison Dynamis Therapeutics  
Davis Diana PhD Associate Director for Research Development Associates, Inc. 
Denman Jeffrey  JD Founding Partner 126 Cathedral Street 
DeSanto Tom  Executive Vice President Aloysius, Butler & Clark 
De Souza Bryan MD Neurologist Lankenau Medical Office 
Building 
Diamond Louis MB, ChB, FACP Vice President & Medical Director MEDSTAT Group 
Docherty John MD President & CEO Comprehensive Neuroscience 
Doshi Dilesh PharmD Associate Director, Regional Outcomes 
Research 
Ortho-McNeil Janssen Scientific 
Affairs, LLC 
Druby Thomas   Vice President of I/T & CIO Blue Cross of NE PA 
Edman David   Managing Partner  Risk Management Partners, LLC  
Eng Benjamin MD, MA  Senior Medical Director, Group Leader  Pfizer Global Pharmaceuticals  
Feldman Michael MD, FACC President, Graduate Education Foundation Graduate Hospital 
Feldman Marc MBA 
  
American Board of Internal 
Medicine 
Fernley G.A. Taylor   President & CEO Fernley & Fernley, Inc. 
Fetterolf Donald MD, MBA Corporate VP Strategic Initiatives Matria Healthcare, Inc. 
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Fleegler Edward MD, FACP Medical Director Independence Blue Cross 
Flynn Mickey   President Pennsylvania BIO  
Freeman Robert PhD Principal The Freeman Group, LLC 
Fried Jeffrey   President and CEO Beebe Medical Center 
George Dawn MBA    Wesley Enhanced Living  
Gerson Benjamin MD Medical Director University Services 
Gill James MD, MPH President, Director of Health Services 
Research Group 
Delaware Valley Outcomes 
Research  
Gitman Paul MD Medical Director, VP Quality Long Island Jewish Medical 
Center 
Gorton Christopher 
(Kit) 
MD, MHSA CMO APS Healthcare, Inc. 
Grusenmeyer Patrick ScD, FACHE  Vice President Christiana Care Health System 
Hadley Trevor PhD Professor of Psychology in Psychiatry Ctr for Mental Health Policy & 
Services Research 
Hamill  C. Taney    Chief Executive Officer Women Business Leaders of the 
U.S. Health Care Industry 
Foundation  
Harris Daniel PhD Senior Project Director The CNA Corporation 
Hayes Winifred PhD President and CEO Hayes, Incorporated 
Helmer Lynn MD, FACP, MBA, FACPE President DRD Consulting, Inc. 
Henochowicz Stuart MD, MBA, FACP 
  
Internal Medicine and Allergy 
Associates 
Herman Barry MD, MMM Senior Director, U.S. Regional Medical & 
Research Specialist 
Pfizer, Inc. 
Hess Gregory MD, MBA, MSc VP, New Product Dev. & Commercialization Surveillance Data Incorporated 
Higashi Mitchell PhD Senior Director Health Economics and 
Outcomes Research / GE Healthcare  
GE Healthcare  
Hughes  Tom PhD Senior Portfolio Scientist  Eli Lilly & Company  
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Jacobs Mark   Director of Technology Services WellSpan Health 
Jacoby Richard MD     
Jhaveri Vishu MD COO & Corp. Med. Director FutureHealth Corporation 
Joffe Howard  Esquire    Best Evidence, Inc.  
Kain Dennis FACHE Senior Vice President Tyler & Company 
Karpay Kenneth    VP & Group Publisher  Physicans Practice  
Katz Gerald   President Kurt Salmon Associates 
Kehr Bruce MD Chairman and CEO InforMedix Inc. 
Kelly John MD, PhD Chief Health and Medical Officer Union Pacific Railroad 
Keshishian Dale   Consultant Gap International, Inc. 
Kim Edward MD, MBA Associate Director Bristol-Myers Squibb Company 
Bob Kocher MD Engagement Manager  McKinsey & Company, Inc. 
Kountz David MD Assoc. Dean for Postgrad Ed. 
Univ. of Medicine & Dentistry of 
NJ 
Kovner Anthony PhD Professor of Public and Health Managment NYU/Wagner Graduate School 
of Public Service 
Lawless Stephen MD Chief Knowledge and Quality Officer Nemours 
Lazarus Arthur MD, MBA Sr. Director of Clinical Research AstraZeneca Pharamaceuticals 
LP 
Leider Harry MD , MBA, FACPE Chief Medical Officer XLHealth 
Lerner Jeffrey PhD President & CEO ECRI 
Locklear Julie PharmD, MBA Associate Director, Outcomes Research AstraZeneca Pharmaceuticals LP 
Longley William   Founder and CEO Scientific Intake 
Luce Bryan PhD, MBA Senior Vice President, Science Policy UBC (United BioSource 
Corporation) 
Lynch John (Jack)   President and CEO Main Line Health 
Macgregor Robert FACHE Manager, Market & Client Development 
Healthcare Consulting 
Parente Randolph, PC 
Maclean Ross MD, MBA Director, Outcomes Research, Immunology Bristol-Myers Squibb Company 
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Markson Leona ScD Executive Director, Outcomes Research & 
Mgmt. 
Merck & Co., Inc. 
Martin Paul   Principal The Paul Martin Company, LLC  
May Jeanette 
  
Director, Research Disease Management Association 
of America (DMAA) 
McCloskey Richard MD VP, Medical  Technology Johnson & Johnson 
Development Corp. 
McGivney William  Ph.D CEO National Comprehensive Cancer 
Network 
McGuckin Maryanne Dr. ScEd., MT  Senior Research Investigator  University of Penn - School of 
Medicine  
McLaughlinq Michael MD Principal, Chief Scientific Officer  Peloton Advantage  
Mehr Stanton   President SM Health Communications  
Messikomer Carla PhD President The Acadia Institute 
Miller Stanton MD, MPH Medical Director Lourdes Health System 
Mirkin David MD Prinicipal & Healthcare Mgmt. Consultant Milliman, Inc. 
Mochan Eugene PhD, DO Associate Dean for Primary Care Philadelphia College of 
Osteopathic Medicine 
Monnier John       
Moore David    Presidential Management Fellow CMS Region III  
Morey John 
  
President/CEO VoxVue Corporation | 
Waltham/Boston 
Morrow Kaye 
  
Assistant Division Director Department of Human Services 
State of NJ 
Murphy Karen   CEO Physicians Health Alliance, Inc. 
Nace David MD VP and CMO Mckesson Health Solutions 
Nash Esther MD Sr. Medical Director, Health Management 
Programs 
 
 
Independence Blue Cross 
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Newman Andrew MD, JD, LLM Associate Director, Health Law Studies and 
Adjunct Professor of Law 
Widener University School of 
Law, Health Law Institute 
Owens  Gary MD     
Paxman Dalton PhD Regional Health Administrator Office of Public Health & 
Science, US DHHS 
Pelberg Arthur MD, MPA President and Chief Medical Officer Schaller Anderson Inc. 
Pendrak Robert MD, MS, ARM, 
DFASHRM 
Risk Mgmt Dir., Medical Professional 
Liability 
Inservco Insurance Services, Inc. 
Peskin Steven MD, MBA EVP and Chief Medical Officer MediMedia USA 
Peterson P. Michael EdD Associate Professor University of Delaware 
Phillips Donald PharmD CEO Vox Medica 
Phipps Etienne PhD Director, Einstein Ctr. for Urban Hlth. Policy 
& Research 
Albert Einstein Healthcare 
Network 
Piper Letty RN, MSN Chief Clinical Operations Officer  Good Shepherd Rehabilitation 
Hospital  
Pressman Gregg MD, FACC Associate Professor of Medicine 
Germantown Community 
Health Services 
Provencher Thomas    Senior Director  Pfizer, Inc.  
Pyenson Bruce FSA, MAAA Principal & Consulting Actuary Milliman, Inc. 
Qaseem Amir MD, PhD, MHA Senior Medical Associate American College of Physicians 
(ACP) 
Sanuj Ravindran MD Principal Radius Ventures 
Resnic JoAnne RN, BSN< MBA  VP, Sales  Mid-Atlantic - CarePages  
Roehl Barbara MD, MBA      
Rohner Thomas MD Emeritus Professor of Surgery Penn State Univ., College of 
Medicine 
Rosko Michael PhD Professor Widener University 
Rupnow Marcia PhD Director, Outcomes Research Ortho-McNeil Janssen Scientific 
Affairs, LLC  
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Sacks Lester MD, MPH, PhD Editor Focus 
Scherpbier Harm  MD     
Schoenfeld Shelley BS  Hospital Relations Strategist  Physicans Practice  
Schrogie John MD Consultant, Clinical Research & Development   
Schwartz Marshall MD Pediatric Surgeon St. Christopher’s Hospital for 
Children 
Seeger Barbara PharmD, RPh, MSA Sr. Corporate Account Manager Centocor, Inc. 
Shafa Mehrdad MD, MMM Chief Medical Officer Maricopa Managed Care Systems 
Shapiro Eve    Medical Writer    
Sheils  Paul      Silverado HealthPartners, LLC  
Sigmond Robert MA   2 Franklintown Boulevard 
Slocum Kim   President KDS Consulting, LLC 
Smith Robin  MD, MBA CEO Phase III Medical Inc. / Neostem 
Smith Cecilia DO Chair, Department of Medicine 
The Reading Hospital & Medical 
Center  
Snow Vincenza MD, FACP Director, Clinical Programs and Quality of 
Care 
American College of Physicians 
(ACP) 
Sokol Michael MD, MS Medical Director, Health Management 
Innovations 
GlaxoSmithKline 
Sorin David  Esquire    Management Mpowerment 
Associates  
Stillman Paula MD, MBA Sr. Vice President Special Projects Christiana Care Health System 
Stombler Robin   President Auburn Health Strategies, LLC 
Tang Boxiong MD., PhD Associate Director for Research Centocor, Inc. 
Tanio Craig MD Principal McKinsey & Company, Inc. 
Terzian Raffi MD, MPH Medical Director, Occupational & Travel 
Health  
Main Line Health 
Toscani Michael PharmD   Clinical Solutions, Inc. 
Totten Zoe MSN, CNM Founder The Full  Yield, Inc. 
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Turpin Robin PhD Director, Outcomes Research & Management Merck & Co., Inc. 
Turzanski Edward    Counselor to the President  La Salle University  
Umland Elena  PharmD Associate Dean for Academic Affairs  TJU-Jefferson College of Health 
Professions  
Valerian Christopher   DO., MMM      
Van Brussel Roger   Vice President, Sales  ICW America 
van Steenwyk John AB, MBA President Health Economics Inc. 
Veit Kenneth  DO., MBA, FACOFP Senior VP, Academic Affairs & Dean  Philadelphia College of 
Osteopathic Medicine 
Villare Robert MD 
  
Delaware Valley Physicians & 
Surgeons, P.A. 
Vinson Carey MD, MPM VP, Quality and Medical Performance 
Management 
Highmark 
Vogel Warren   
Esquire  
Eckert Seamans Cherin & 
Mellott, LLC 
Vogenberg F. Randy RPh, PhD Senior Vice President Aon Consulting, Inc. 
White Richard PhD, Mbe Director Pharmacoeconomics and Outcomes 
Research 
Endo Pharmaceuticals 
Wiesendanger John 
  
Chief Executive Officer West Virginia Medical Institute, 
Inc. 
Woods W. David PhD President Healthcare Media International, 
Inc. 
Wright Robert M.D., FACP Director Scranton Temple Residency 
Program 
Zajac Thomas  MBA  President CareScience 
Zeddies Timothy PhD, MHSA Senior Director Research & Evaluation Independence Blue Cross  
Zinn Jacqueline S. PhD Program Coordinator Temple University  
Zissman Joshua FACHE, CPHQ, MBA  Administrator Thomas Jefferson University 
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